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INTRODUCTION 
The decoding of genetic information in the cell involves gene transcription and 
translation. Translation is the process of protein synthesis that gives rise to a variety of 
proteins with different properties and cellular functions that play very important roles in 
all living organisms. Protein biosynthesis involves three phases; initiation, elongation and 
termination, and requires many important cellular factors as well as macromolecules, 
including transfer RNAs that carry amino acids attached to their 3' ends, ribosomes, 
initiation, elongation, and termination factors, etc. During the translational cycle, two 
regions of the tRNA molecule, the anticodon triplet and the 3' CCA end of tRNA, must 
actively participate in protein synthesis and contribute to the efficiency and fidelity of 
protein synthesis. In contrast, during aminoacylation of tRNA, which is a step prior to 
the initiation of protein synthesis, several additional regions of tRNA must interact 
properly with the aminoacyl-tRNA synthetase in order to charge the tRNA with its 
cognate amino acid with high specificity. 
The 3' CCA end of transfer RNA is conserved in all tRNA species from prokaryotes 
to eukaryotes and is a site where an amino acid is attached as a result of aminoacylation. 
The 3' end of tRNA is actively involved in many steps of protein synthesis, including the 
formation of the ternary complex EF-Tu • GTP • aminoacyl tRNA and the binding of 
tRNA to the ribosomal A, P and E sites during the translation process (1). Despite 
increasing knowledge about the roles of the 3' CCA end of tRNA during the last two 
decades, information obtained regarding the role of the 3' end of tRNA in aminoacylation 
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and later steps of protein synthesis has been highly limited to E. coli phenylalanine 
tRNA. Previous information gives only a rather crude picture of the role of the 3' end of 
tRNA in these processes (1) due partly to the complexity of the protein synthesis 
machinery, and to the obstacles encountered in research techniques and methodology. 
Therefore, a further understanding of the involvement of the 3' end of tRNA in 
aminoacylation and other steps of protein synthesis is necessary. With the help of 
modern advanced DNA cloning and site-directed mutagenesis techniques, we have 
developed an approach that can modify the 3' end of any tRNA species systematically 
and obtain 3' end-modified tRNA transcripts in vitro using the T7 RNA transcription 
system (2) in order to investigate, in depth, the roles of the 3' end of valine transfer 
RNA in both aminoacylation and the later steps of protein synthesis. 
The efficiency and fidelity of protein biosynthesis depend not only on events 
occurring on the ribosome during protein synthesis that includes specific codon-anticodon 
recognition and tRNA ribosomal bindmg, but they also depend on how accurately each 
tRNA molecule is charged with its cognate amino acid during aminoacylation, which is a 
process catalyzed by aminoacyl-tRNA synthetases. All tRNAs adopt similar L-shaped 
tertiary structures with similar size. Each aminoacyl-tRNA synthetase must specifically 
recognize its cognate tRNA(s) while discriminating against a pool of 19 sets of other 
tRNAs in the cell, so that the efficiency and fidelity of protein synthesis can be achieved. 
Aminoacylation specificity of a tRNA is determined not only by the positive identity 
elements that play an important role in specific tRNA-synthetase recognition, but also by 
those nucleotides or soructure features present on noncognate tRNAs that prevent 
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productive interactions between noncognate tRNAs and the synthetase. A number of 
biochemical, molecular biology and physicochemical approaches have been developed to 
study tRNA structure and fimction, many of which use tRNAs that are modified 
chemically or enzymatically to study the function of tRNA m aminoacylation in vitro or 
in vivo (1, 3, 4, 5, 6). We have been investigatmg the structure-function relationship of 
E. coli valine transfer RNA and the recognition of this tRNA by valyl-tRNA synthetase 
(VRS). We use a site-directed mutagenesis approach to introduce mutations into the 
tRNA^"* gene, and obtain tRNA transcripts tiirough in vitro transcription to study the 
aminoacylation activity of the modified tRNA. We also study the effect of mutations on 
tRNA structure by "F NMR spectroscopy of 5-fluorouracil-substituted tRNA^"'. Study of 
the recognition of tRNA by synthetases will help us understand how the specificities for 
ammoacylation of different tRNAs are achieved. 
Structure and Functions of Transfer RNA 
General Structure nf Transfer RNA 
The first determination of the prunary structure of transfer RNA was carried out by 
Holley et al. (7) on yeast alanine transfer RNA. Since then, the sequences of more than 
1700 tRNAs originating from more than 130 organisms have been determined (8). From 
the structural information of all the tRNA molecules in different organisms, it was 
inferred that transfer RNAs adopt a cloverleaf secondary structure. All known transfer 
RNAs share the following conmion features: they are single chains containing between 73 
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and 93 ribonucleotides. The 5' terminus of tRNA is phosphorylated, whereas the 3' 
terminus has a free hydroxyl group. Transfer RNAs contain many unusual modified 
bases, typically between 7-15 per molecule, many of which are methylated or 
dimethylated derivatives of A, U, C and G, that are formed by enzymatic modification of 
a precursor tRNA. In addition, the modified bases play important roles in stabilizing the 
tertiary structure of tRNA, facilitating the interactions between tRNAs and aminoacyl-
tRNA synthetases, and increasing the efficiency and fidelity of protein synthesis. All 
tRNA molecules contain the universally conserved 3' end CCA sequence that is the site 
of amino acid attachment as a result of aminoacylation of the tRNA. About half of the 
nucleotides in tRNAs are base paired to form double helices, including the acceptor stem, 
the D-stem, T-stem and the anticodon stem. Five groups of bases are not base paired, 
these include the 3' CCA end, the T^C loop, the variable loop, the DHU loop and the 
anticodon loop. Figure 1 shows the typical secondary and tertiary structure of tRNA that 
is based on x-ray crystallographic study of the three dimensional structure of yeast 
tRNA"" (9, 10). Transfer RNAs are divided into two classes based on the length of the 
variable loop; class I tRNAs contain short variable sequences of four to five nucleotides, 
whereas class II tRNAs contain a variable loop of ten or more nucleotides. Class II 
tRNAs also contain a purine-purine conserved base pair at position 13-22 in the D-stem 
instead of the classical Watson-Crick pair found in class I tRNAs (11). From x-ray 
crystal structure studies of the three dimensional structore of four tRNAs, yeast tRNA"*® 
(3), tRNA^^(12), tRNA^®' (13) and E. coli tRNA"^®' (14), it was generally accepted that 
the tRNA molecules adopt an L-shaped structure mainly by unusual hydrogen-bond 
Figure 1. Structural features of transfer RNA. 
(A) Generalized cloverleaf structure of tRNA. Invariant and semi-
invariant residues are designated by capital letters. R is purine, Y is 
pyrimidine, and H is hypermodified purine, 
(B) three-dimensional structure of tRNAs. The horizontal part of the 
L-shaped structure is formed by colinear stacking of base-paired 
regions in the acceptor stem and the stem whereas the vertical 
part has base-pairs in the D-stem stacked over the anticodon stem 
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formation between conserved or semi-conserved bases in the DHU stem and the T-loop, 
so that two segments of double helix perpendicular to one another are formed. This 
unusual hydrogen-bonding formation gives the molecule its L-shape where the DHU and 
T^C loops form the comer of the L-shape. The structure is about 60 A in length, and 
20 A in diameter. The distance between the 3' CCA end and the anticodon loop of 
tRNA is about 80 A. 
Nuclear magnetic resonance (NMR) spectroscopy provides insights into both the 
structures and dynamics of tRNAs. A large number of NMR studies have been 
performed mostly on yeast tRNA^' (15, 16). These studies provided information about 
the thermal stability of tRNAs and showed that double helical regions of tRNA are 
relatively stable, whereas the tertiary structure and D-stem base pairs are less stable. 
Some recent NMR studies have been performed on tRNA transcripts that lack the 
modified bases. These studies suggested that modified bases in tRNAs play important 
roles in stabilizing tRNA tertiary structure (17, 18, 19). 
Structural data on tRNAs can also be obtained by computer modelmg using data 
derived from chemical mapping in solution. Models incorporate known structural motifs 
from crystallographic or NMR studies. These studies provided new information about 
other tRNAs including tRNA""', tRNA'^, tRNA"'', and tRNA^^(20). tRNA 
conformation and dynamics in solution have been monitored by many biophysical 
methods other than NMR, including Raman spectroscopy, and electro-optical 
measurements (21). 
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Functions nf Transfer RNA 
Transfer RNA plays an important role in facilitating the transfer of the genetic 
information from messenger RNA to protein through the translation process which takes 
place on 70S (prokaryote) or SOS ribosomes (eukaryote) and includes messenger RNA, 
tRNA, as well as many other factors necessary for protein synthesis. During the 
translation process the anticodon triplet of tRNA must recognize the base triplet (codon) 
on messenger RNA and form a proper base pair with the codon. This codon-anticodon 
recognition process specifies the identity of an amino acid incorporated at a certain 
position in the polypeptide chain. Before participating in protein synthesis, an amino acid 
is esterified to the 2' or 3' hydroxyl group of the 3' ribose moiety at the 3' CCA end of a 
tRNA. This process is called aminoacylation and is catalyzed by an aminoacyl-tRNA 
synthetase. The aminoacylated tRNA then joins the protein synthesis machinery and 
transfers the amino acid to the growing polypeptide chain. 
Protein synthesis takes place on ribosomes which consist of a large and a small 
subunit. In E. coli, the 70S ribosome (2700 kd) is made up of 30S and SOS subunits. 
Protein synthesis takes place in three phases: initiation, elongation, and termination. In 
procaryotes, the initiator tRNA, also called formylmethionyl-tRNAf, is involved in the 
formation of a 30S initiation complex with the 30S ribosome, this is then joined by the 
SOS ribosomal subunit to form a 70S initiation complex. In the elongation process, 
aminoacyl-tRNA first participates in the formation of a ternary complex: EF-Tu • GTP • 
aminoacyl-tRNA. The ternary complex then binds to the A site of the 70S ribosome to 
begin the elongation phase. A peptide bond is formed between the activated carboxyl 
group of the growing peptide chain and the amino group of the ammoacyl-tRNA, 
catalyzed by the peptidyl transferase center of the large ribosomal subunit. The resultant 
uncharged tRNA leaves the P site and moves to the exit site (E site), and finally 
dissociates from the ribosome. Meanwhile, the peptidyl-tRNA moves from the A to the 
P site, resulting in an empty A site ready for the next aminoacyl-tRNA molecule. These 
processes comprise a translocation cycle that is catalyzed by elongation factor-G (EF-G or 
translocase). Protein synthesis is terminated by release factors that recognize the 
termination codons and cause the hydrolysis of the bond between the polypeptide chain 
and tRNA (22). Transfer RNA plays similar roles in protein synthesis in eukaryotes as it 
does in prokaryotes. 
In addition to the important role transfer RNA plays in protein synthesis, it is also 
involved in the regulation of amino acid biosynthesis, the regulation of amino acid 
transport, the priming of transcription by the reverse transcriptase of RNA tumor viruses 
(23), and regulation of the stringent response. Recent studies show that tRNA is also 
involved in the regulation of chlorophyll biosynthesis (24). 
Roles of the 3'-CCA End of Transfer RNA in Aminnacvlation and Protein Synthesis 
The 3'-CCA end of tRNA is conserved in all tRNA species in prokaryotic and 
eukaryotic organisms. It is single-stranded. A number of previous studies on the 
structure of the 3' CCA end of tRNA include x-ray diffraction studies, chemical 
modification and NMR studies. These studies demonstrated that the single-stranded CCA 
end of tRNA possesses an ordered structure that is stabilized by vertical stacking 
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interactions on the aminoacyl stem (1). They also suggested that such a structure may be 
important for determining the steric arrangement of the 3' adenosine and facilitating the 
interaction of the CCA end with other macromolecules, such as aminoacyi-tRNA 
synthetases, elongation factors and ribosomes, during the functional cycle of tRNA (1). 
The 2' or 3' hydroxyl group on the ribose moiety of the 3' terminal A of tRNA is the 
site of amino acid attachment. A number of studies have been carried out to investigate 
the role of the 3' CCA end of tRNA in aminoacylation. These studies were performed 
mainly on yeast phenylalanine tRNA using different chemical and enzymatic modification 
approaches. Previous results showed that a complete 3'-CCA end of tRNA is an absolute 
requirement for aminoacylation of a tRNA by its cognate synthetase (1). Whereas 
shortened tRNA species cannot accept amino acids, some 3' end modified tRNAs with 
one nucleotide longer, including yeast tRNA""® with a 3' end sequence CCCA, instead of 
CCA, can accept amino acids, even though the efficiency of aminoacylation of these 
modified tRNAs is much lower than those of natural tRNAs (25). In many cases, 
modifications of the 3' terminal adenosine residue of tRNA resulted in either a total loss 
or a dramatic decrease in aminoacylation activity of tRNA, due largely to a decrease in 
the maximal velocity of the reaction (26, 27, 28). Modifications of the ribose moiety of 
the terminal nucleotide of tRNA, including E. coli tRNA^"', were also performed, by 
periodate oxidation and borohydride reduction of the ribose (1, 29, 30). These studies 
showed that the aminoacylation abilities of the modified tRNAs were either appreciably 
reduced or severely damaged. 
Different types of modifications on the 3' penultimate cytidine residues at positions 
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74 and 75 of yeast tRNA^ had differential effects on the ability of the tRNA to accept 
its cognate amino acid. Kucan et al. (31) reported that yeast tRNA""^ having UUA at its 
3'- end is actively aminoacylated. In other cases, introducing sulfur groups into the 
cytidine residues also had litde effect on its aminoacylation ability (32). A bulky group, 
such as an alkyl substitution introduced into position 75 of tRNA"^*", however, abolished 
its aminoacylation activity (33). It appears that in many cases, although the K„ values of 
modified tRNAs remain essentially unchanged, the Vn^ values are significantly lowered 
upon modifications of the 3' Cs. Based on ammoacylation kinetic studies of 3' terminally 
modified yeast tRNA"", it was hypothesized that the 3' adenosine may trigger a 
conformational change of the synthetase during the recognition process, leading to a 
tighter binding of tRNA to the synthetase and efficient aminoacylation (28). 
Taken together, previous studies showed that the 3' end of tRNA is important for the 
aminoacylation activity of the molecule. Modifications on the 3' terminal adenosine 
residue usually reduce aminoacylation efficiency very dramatically. These studies 
showed that the same modifications introduced into the 3' adenosine of different tRNAs 
with different specificities from different origins have differential effect on the 
aminoacylation activity of tRNAs (1), suggesting that the interactions between the 3' 
CCA end of different tRNAs and their cognate synthetases are different. Perhaps no 
general rules can be applied to all tRNA-synthetase systems. 
The aminoacylation reaction of tRNA, which occurs at the 3' CCA end, is a key 
reaction in distinguishing among the 20 amino acids. After the amino acid is attached to 
tRNA, there is no other discrimination step (34). There are several cases known in 
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which the first step of aminoacylation of tRNA, the activation of the ammo acid by ATP, 
is not very specific. In these cases, the discrimination occurs mainly in the second step 
during the transfer of the amino acid from the aminoacyl-AMP to the 3' end of tRNA. 
The best-known example is the mischarging of valme by isoleucyl-tRNA synthetase (35). 
It is known that some synthetases possess a hydrolytic capacity (36), and when an 
incorrect amino acid is esterified to the 3' end of a tRNA, the synthetase hydrolyzes the 
resultant mischarged aminoacyl-tRNA. Studies suggested that the 3' end of tRNA, 
particularly the 3' hydroxyl group on the 3' terminal ribose, is involved in the chemical 
proofreading mechanism of the synthetase which hydrolyzes the incorrectly formed valyl-
tRNA"' (37). The mischarging of tRNA^®' with threonine was also extensively studied 
(38), and it was proposed that the 3' hydroxyl group on the 3' end ribose moiety of the 
tRNA is also involved in the proofreading mechanism of valyl-tRNA synthetase (39). 
In addition to the role the 3' CCA end of tRNA plays in the aminoacylation 
reaction, crystallographic studies, chemical probing, and nuclease protection stodies 
suggested that it also participates in the later steps of protein synthesis, including the 
formation of ternary complex EF-Tu • GTP • aminoacyl-tRNA, and the binding of 
tRNA to 23S rRNA at the A, P, and E sites of the SOS ribosomal subunit durmg the 
elongation and translocation steps of the translation cycle (1, 40, 41, 42, 43, 44). Recent 
studies showed that the 3' end of tRNA protects some residues of 23S rRNA in the SOS 
ribosomal subunit from chemical modification (41). Furthermore, mutations that altered 
or deleted the 3' end sequence of tRNA resulted in a loss of protection of the 
corresponding nucleotides on 23S rRNA. Based on the evidence it has been suggested 
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that the interaction between the CCA sequence and a complementary sequence within the 
central loop of domain V of 23S rRNA is involved in tRNA binding to the peptidyl 
transferase center. Further evidence for the importance of the CCA end in E site tRNA 
binding comes from the work of Wintermeyer and co-workers who demonstrated that 
tRNA binding to the E site is dramatically reduced by changes at the 3' end, and 
hypothesized that base pairing between the 3' end of tRNA and a U on the 23S rRNA at 
the ribosomal E site is important for the translocation step (42). O'Connor et al. used 
tRNA^®' mutants with substitutions at position 74 to study the effect of the 3' end on the 
codon-anticodon interaction and the fidelity of protein synthesis (45). They showed that 
although the 3' end mutants ACA, GCA, and UCA of tRNA^®* retain significant 
aminoacylation activity, disruption of interactions between the CCA end of tRNA and the 
large ribosomal subunit promotes aberrant codon-anticodon interactions on the small 
ribosomal subunit. These results suggest that distortion of the interactions between the 3' 
end of tRNA and the P site affects the conformation of the allosterically coupled A site 
and allows binding of near-cognate tRNAs, resulting in a decrease in the fidelity of 
protein synthesis. 
Different approaches have been taken to study the role of the 3'-CCA end of tRNA in 
aminoacylation and other aspects of protein synthesis. Many conclusions regarding the 
function of the 3' terminal residue (A76) of tRNA were based mainly on the study of 3' 
end modified yeast tRNA^° (1). Many of the modifications introduced into its 3' end 
were the results of either chemical modifications that usually have drawbacks of 
introducing bulky groups into the position studied, resulting in difficulties in 
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interpretation. Some of the modifications were carried out by using ATP(CTP):tRNA 
nucleotidyltransferase to incorporate modified adenosine and cytidine into the 3' end 
positions 74, 75, and 76 of the tRNA. These enzymatic modifications on 3' end 
adenosine and cytidine were rather limited in order to make sure that the enzyme can still 
use the modified bases as substrates and incorporate them into the 3' end of tRNA. No 
appropriate method has previously been established to systematically alter the 3' end 
sequence of tRNA in order to study the effect of 3' end mutations on the function of 
tRNA in aminoacylation and other steps of protein synthesis. This experimental difficulty 
was recently overcome in our laboratory (see Methods and Results). 
5-Fluorouracil-Substituted Transfer RNAs 
Properties of 5-Fluorouracil-Substituted tRNAs 
5-Fluorouracil (FUra) was first synthesized as a drug for the chemotherapy of a 
number of cancers (46), and later was shown to be incorporated into cellular RNA and 
cellular DNA (47). The primary mechanism of the anticancer activity of FUra is 
generally believed to involve the inhibition of thymidylate synthetase by the in vivo 5-
fluorouracil metabolite, 5-fluoro-2'-deoxyuridine 5'-monophosphate (FdUMP), in which 
FdUMP acts as a suicide inhibitor of thymidylate synthetase (48). Incorporation of this 
pyrimidine analogue into bacterial E. coli transfer RNA in vivo was first reported by 
Horowitz and Chargaff (49). Later, the in vitro incorporation of FUra into tRNA 
transcripts was reported by Chu and Horowitz (50). Incorporation of FUra residues into 
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tRNA results in the replacement of normal uridine residues and uridine-derived modified 
nucleosides such as pseudouridine, and ribothymidine by FUra. The resulting 
modification-deficient tRNAs, with few exceptions (51), remain functional in protein 
synthesis and have been found to be useful to study the roles of modified nucleosides m 
tRNA structure and functions (52, 53, 54, 55). 
FUra-substituted E. coli tRNA^*" has been purified and extensively studied. Only 2 
out of 7 modified bases remain in in vivo synthesized FUra-substituted tRNA^®*. 
Physicochemical studies showed that the absence of modified bases and the extensive 
incorporation of FUra residues into many tRNAs have little effect on tRNA structure 
(52). Biochemical smdies showed that the aminoacylation kmetic parameters (Vp,.v and 
KJ of (FUra)tRNA^'' remain essentially unchanged compared to those of native wild 
type tRNA^** (50, 52). It was also found that (Fura)tRNA^''' remains almost fully active 
in protein synthesis (53); the ability of (FUra)tRNA^'^ to participate in formation of the 
ternary complex, EF-Tu • GTP • aminoacyl-tRNA, tRNA ribosomal binding, and protein 
synthesis are all unchanged in rate and extent compared to normal wild type tRNA^®* that 
contains modified bases. These studies demonstrate that 5-fluorouracil-substituted 
tRNA^*' is fully biologically active and has physical properties that resemble those of 
normal tRNA^"*. Therefore, (FUra)tRNA^'^ can be used as a good model for studying the 
structure and function of tRNA^®* by '®F NMR spectroscopy. 
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NMR Study of S-Flnoronracil-Substituted tRNAs 
NMR study of transfer RNAs 
Nuclear magnetic resonance (NMR), because of its high resolution, has been used 
extensively to study the structure and dynamics of tRNA in solution, A number of nuclei 
have been used in these studies, including protons and "F and "N (56). Proton 
NMR studies have been largely limited to observation of either the hydrogen-bonded 
imino protons of the secondary and tertiary base pairs or the methyl and methylene 
protons of modified bases. Most NMR studies of tRNAs have the disadvantage of not 
yielding structural information about loop structure. It is almost impossible to study 
tRNA and synthetase interaction using NMR technique since there are large number of 
protons in the two macromolecules and they overlap in the 'H NMR spectrum. Some of 
these problems can be overcome by other NMR techniques, such as two-
dimensional NMR (57, 58), ^^P NMR, or "C NMR. However, these methods suffer 
from a lack of sensitivity, and "C NMR technique requires the use of isotope-eirichment 
procedures. 
NMR studies of transfer RNA 
Fluorine-19 NMR study of 5-fluorouracil-substituted tRNAs is a powerful and 
sensitive method to investigate the solution structure of tRNA (50, 59, 60, 61, 62, 63). 
The fluorine nucleus offers a number of advantages including 100% natural abundance, a 
large range of chemical shifts, a high sensitivity (83% that of ^H), and no interference 
from protein in the spectra of protein-tRNA complexes. 5-fluorouracil-substituted tRNAs 
are well suited to ^'F NMR studies because of the high degree of fluorine incorporation, 
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and because many of these (FUra)tRNAs, including (FUra)tRNA'*'*', remain fully active in 
protein synthesis. 5-fluorouracil is incorporated into every stem and loop of tRNA, 
making it possible to obtain information on loop and stem regions, as well as die tertiary 
interactions (50, 61, 64). There are 14 5-fluorouracil residues distributed throughout 
every stem and loop of tRNA^** molecule (Figure 2), which can serve as site-specific 
reporter groups to simultaneously monitor all parts of the tRNA. The secondary structure 
and tertiary folding of the tRNA molecule place each 5-fluorouracil residue in an unique 
chemical environment, resulting in a "F NMR spectrum with a resolved resonance for 
each incorporated FUra residues. The "F NMR spectrum of (Fura)tRNA^'', recorded at 
22°C in the presence of 15 mM Mg^"^ and 1(X) mM Na"^, shows 12 well resolved peaks 
(Figiu-e 3a) (50). When the "F NMR spectrum of (FUra)tRNA is recorded at 47°C, 
under the same condition, it shows 13 well resolved peaks (FigureSb). Complete 
assignment of the "F NMR spectrum of (FUra)tRNA^°'was recently accomplished in this 
laboratory using a variety of chemical, physical and biochemical techniques (50, 61, 65, 
66). 
^'F NMR studies show that the five FUra residues in the relatively unstructured loop 
regions of tRNA^®* correspond to the resonances in the central region of the ^®F NMR 
spectrum. FUra residues base-pairing with A, located at the stem regions of tRNA^®', are 
generally found to correspond to the resonances m the upfield region of the spectrum, 
widi the exception of FU7 that resonates in the central region of the ''F NMR spectrum. 
In contrast, residue FU59, and FU55 which is involved in tertiary interaction in the 
tRNA, correspond to resonances in the downfield region of the spectrum (50, 61, 65). 
Figure 2. Cloverleaf structure of E. coli valine transfer RNA with uracil and uracil-
derived bases replaced by 5-fluorouracil (F) Bases which are invariant in all 
tRNAs are enclosed in boxes. Tertiary base pairs involving 5-fluorouracil are 
connected by solid lines. 
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Figure 3. Summary of resonance assignments in the "F NMR spectrum of in vitro 
transcribed FUra-substituted wild type tRNA^®'. Peak numbers correspond to 
positions of the 5-fluorouracil residues in the tRNA molecule (A) spectrum 
recorded at 22°C. (B) spectrum recorded at 47°C. 
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FU64, which forms a wobble base pair with G at position 50, also resonates in the 
downfield part of the spectrum (50). When four other FU-A base pairs were replaced by 
FU-G base panrs, it was found that the resonances corresponding to FU residues base 
paired to G were shifted 4-5 ppm downfield in the spectra of the tRNA. Complete 
assignment of all the resonances in the ^'F NMR spectrum of (FUra)tRNA^''', showed in 
Figure 3 (66), permits us to study the structure of the tRNA molecule and the effect of 
mutations on conformational changes in tRNA^'', by ^®F NMR spectroscopy. 
^'F NMR study of (FUra)tRNA^*' showed that at 15 mM Mg^"^ the spectra of die in 
vitro transcript and native (FUra)tRNA^^ are identical except for small shifts of 
resonances in the central region of the spectrum (50). This suggests that there are few if 
any significant structural differences between synthetic and native (FUra)tRNA^*' under 
these conditions. However, in the absence of Mg^"^, the ^®F NMR spectra of the in vitro 
transcript and native (FUra)tRNA^"' differ markedly especially in the upfield region (50), 
suggesting that the secondary and tertiary structure of the transcript is less stable than that 
of native tRNA under low Mg^"^ concentration. "F NMR study of the thermal unfolding 
of (FUra)tRNA^*' was done by Wen-Chy Chu (63), and the results suggested that the 
initial steps of thermal denaturation of tRNA^"^ involve disruption of the tertiary 
interaction between the D and T-stems, and that the acceptor stem is much more stable to 
thermal denaturation. 
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Recognition of Transfer RNAs by Their Cognate Aminoacyl tRNA Synthetases 
Characten«rtips nf Aminoacvl tRNA Synthetases 
Aminoacyl tRNA synthetases are found in all living organisms (69). There are 
twenty different aminoacyl tRNA synthetases in the cell, one for each amino acid. Each 
synthetase catalyzes the esterification of its cognate amino acid to a hydroxyl group at the 
3' end of its cognate transfer RNA. The well-established general mechanism of the 
aminoacylation reaction includes two steps: the first is synthesis of an aminoacyl 
adenylate, the activation of an amino acid, followed by a second step in which the amino 
acid is transferred from the aminoacyl adenylate to a hydroxyl group at the 3' end of 
tRNA (69). 
Aminoacyl tRNA synthetases are functionally homogeneous but structurally extremely 
heterogeneous, with sizes in E. coli ranging from 51 kDa (cysteinyl-tRNA synthetase) 
(CysRS) (70) to 384 kDa (alaninyl-tRNA synthetase (AlaRS) (71). These enzymes also 
exhibit diverse a, Uz, a^, or a^2 quaternary structures. The length of the polypeptide 
chain ranges from 334 amino acids in tryptophanyl-tRNA synthetase (TrpRS) (72) to 
1112 amino acids in phenylalaninyl-tRNA synthetase (PheRS) (73). The properties of the 
aminoacyl-tRNA synthetases have been extensively studied (74, 75). Sequence 
comparison and a number of biochemical studies revealed that synthetases can be divided 
into two groups of 10 each (76). Class I synthetases contain two conserved signature 
sequences: HIGH and KMSKS. HIGH is located near the amino-terminal of all the 
synthetases in this group and is part of a subdomain of the synthetases resembling a 
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Rossmann-fold (a parallel sheet of five jS-strands flanked by a-helices) that is involved in 
ATP binding and is found in many other ATP-binding proteins (77, 78). Another 
signature sequence, KMSKS, shared by these synthetases, is reported to be involved in 
the binding of ATP, binding of the 3' end of the tRNA molecule, and activation of the 
amino acid (79, 80). The ten class II aminoacyl tRNA synthetases do not contain the two 
signature sequences mentioned above and have different ATP-binding domains. Instead, 
three characteristic motifs containing an antiparallel j8-sheet flanked by two a-helices are 
found in this group of synthetases. The separation of twenty synthetases into these two 
classes is reflected in the three-dimensional structural and the mechanistic levels. X-ray 
crystallographic studies of B. stearothermophilus TyrRS (81), E. coli MetRS (82), and E. 
coli GlnRS (83) indicated that all class I enzymes probably possess a classical Rossmann-
fold nucleotide binding domain. Furthermore, these synthetases charge tRNA on the 2'-
OH group of the 3' terminal ribose. Class II synthetases, such as E. coli SerRS (84) and 
yeast AspRS, (85) charge tRNAs on the 3'-0H group of the 3' terminal ribose. It is 
believed that the two classes of syntiietase evolved fi-om two different active site domains 
by insertion and addition of modules that are folded differently. Schimmel (86) proposed 
a general scheme for the structural arrangement of aminoacyl-tRNA synthetases in terms 
of functional units along the amino acid sequence. He proposed that sequences located 
within the amino terminal halves of the proteins are responsible for synthesis of 
aminoacyl adenylate, while the sequences located near the carboxyl terminal domain of 
the enzymes are responsible for tRNA recognition. The proposed structural arrangement 
of the aminoacyl tRNA synthetases is consistent with the results of crystal structure 
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studies of E. coli GlnRS complexed with tRNA®"" (83), Thermus thermophilus SerRS 
complexed with tRNA®" (87), and yeast AspRS complexed with tRNA"^ (85) (see 
below). 
In addition to the important role aminoacyl tRNA synthetases play in tRNA 
charging, it was found that at least some of these enzymes also play roles in either 
regulating then: own expression (86) or the assembly of synthetase complexes inside die 
cell (in eukaryotes). The regulatory mechanisms vary from one enzyme to another, and 
were found to be as diverse as the synthetases themselves. Recent studies indicate that 
some part of the amino acid sequences of synthetases that are not required for 
aminoacylation activity, and thus are dispensable in this sense, are probably involved in 
these regulatory functions (86). 
Methodology of Studying Recognition of tRNAs hv Aminnarvl-tRNA Synthetases 
Several approaches have been used to study tRNA-synthetase interaction (6, 88, 89). 
The first involves in vitro assays in which tRNAs obtained directly from cells, or tRNAs 
that are chemically or enzymatically synthesized in vitro are used. In early studies, 
chemical modification experiments were carried out on tRNAs in order to identify sites 
on tRNAs that are important for their function (90). Nonsense and missense suppressor 
tRNAs, generated in genetic experiments, were also isolated from cells for in vitro 
studies (91, 92). In 1982, a method for in vitro replacement of the anticodon, using T4 
RNA ligase, was developed (93), and the modified tRNAs were used to study tRNA-
synthetase interaction. Recently, a number of synthetic tRNA genes have been cloned. 
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and many tRNAs have been overproduced and purified from ceils for in vitro study (94, 
95, 96). With the cloned tRNA genes available, oligonucleotide-directed mutagenesis of 
tRNA genes can be carried out to obtain mutated tRNA genes with any desired sequence, 
and in vitro transcription of the tRNA genes, using T7 RNA polymerase, can be 
performed to obtain tRNA transcripts in large quantities for biochemical and physical 
studies (17). 
While much information can be obtained about synthetase-tRNA recognition from the 
in vitro approach, to fiilly understand how synthetases recognize theL' cognate tRNAs and 
discriminate against a pool of 19 different sets of noncognate tRNAs in order to prevent 
mischarging, it is important to study tRNA-synthetase interaction using in vivo 
approaches. Early studies used amber suppressor derivatives of E. coli tRNA^^. Genetic 
selection was used for tRNA base changes that allow suppression of amber codons at sites 
where tyrosine insertion fails to yield a biologically active protein (97, 98). With the 
help of the new mettiod of automated DNA synthesis, E. coli amber suppressor tRNAs 
containing any desired modified sequences outside the anticodon triplet can be obtained. 
These suppressor tRNAs were then used to insert amino acids into a specific site in a 
reporter protein where an amber codon is located, usually at position 10 of £. coli 
dihydrofolate reductase (DHFR). The identity of the inserted amino acid can therefore be 
determined by protein sequencing. A lot of information regarding the identity elements 
of tRNAs has been obtained using tiiis novel in vivo approach (89). 
The inability to assay tRNAs containing wild type anticodons has been a major 
problem in the in vivo approach mentioned above. Recently, Schulman et al. (99, 100) 
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have modified this approach, and developed a new method in which the E. coli initiator 
tRNA (tRNA°^") is used to study the effects of specific mutations on amino-acid-acceptor 
specificity. Using this approach, cloned tRNA^" genes containing non-methionine 
anticodons can be expressed in cells harboring a compatible plasmid that carries a target 
protein (DHFR) gene with a complementary non-methionine initiation codon. This assay 
provides a way of examining, in vivo, the effects of mutations in otiier regions of a 
tRNA, that contains a wild type anticodon sequence, on the identity of a tRNA (100). In 
addition, it also makes it possible to test the effects of any anticodon base changes on 
tRNA identity in vivo. The amino acid at the amino terminus of the protein is identified 
by protein sequencing to determine the amino-acid-acceptor specificity of the tRNA. 
Both the in vitro and in vivo approaches have provided us with much useful 
information about the identity elements of tRNAs required for recognition by aminoacyl 
tRNA synthetases. 
Other physical and biochemical approaches have also been used to study tRNA-
synthetase interaction. Whereas UV crosslinking between tRNAs and synthetases and 
footprinting of tRNA-synthetase complex have provided us with much information (6), a 
very powerful and more direct approach to study tRNA-synthetase interactions has been 
x-ray crystallography of tRNA-synthetase complexes. X-ray crystal structures of three 
tRNA-synthetase complexes have been obtained to atomic resolution. The determination 
of the crystal structure of E. coli tRNA°'"-GlnRS complex (class I) (83), yeast tRNA'^-
AspRS complex (class II) (85), and T. thermophilus tRNA®"-SerRS (class II) are certainly 
major achievements for understanding tRNA-synthetase interaction at the molecular level. 
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In the case of GlnRS and AspRS complexed with their cognate tRNAs, the synthetases 
span the tRNA from the acceptor stem to the anticodon region and interact specifically 
with the nucleotides in the anticodon loop of the two tRNA. One common feature of all 
the three synthetase-tRNA interactions is that important conformational changes occur in 
tRNAs as a result of synthetase binding. In the case of tRNA®"", beside the anticodon 
loop and stem regions that undergo large conformational changes, the terminal base pair 
of the acceptor stem is disrupted, resulting in an opening of the first base pair that is 
stabilized by RNA-RNA interactions between the amino group of the discriminator base 
G73 and the first base pair. As a result of the synthetase-tRNA interaction, the 3' CCA 
end of tRNA®"" is distorted and kinked, forming a hairpin structure with the 3' terminus 
folding back toward the acceptor stem of the tRNA. Conversely, in tRNA'^-AspRS 
complex, the 3'-CCA end retains its helical continuity with the acceptor stem. Another 
difference between the GlnRS and AspRS complexes is the orientation of the two 
syntiietases with respect to the tRNAs. Whereas GlnRS approaches tRNA®*" from the 
minor groove side of the acceptor stem, AspRS approaches from the major groove side of 
the acceptor stem of tRNA"^^. These opposite ways of approaching the tRNA molecule 
are likely to be representative of the recognition of tRNAs by many synthetases that 
interact specifically with nucleotides in the anticodon loop of tRNAs (6). In contrast, T. 
thermophilus SerRS interacts only with the variable stem and minor groove, as well as 
the D and T\j/C loops of tRNA®", and most of the interactions are between the side-chains 
of the synthetase and the phosphate-sugar backbone of the tRNA. tRNA®®^ is one of the 
several unique tRNAs that contain a long variable stem (containing 20 nucleotides) and 
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have important synthetase recognition sites outside the anticodon loop of tRNA. 
Molecular Basis for Recognirion of tRNAs hv Aminoacvl-tRNA Synthetases 
All tRNAs have shnilar secondary and tertiary structures, yet each syndietase must 
specifically recognize its cognate set of tRNA while discriminating against all others. 
This recognition is generally believed to occur in two steps: the first step involves the 
initial binding of tRNA to synthetase, and the second step involves a conformational 
change in the enzyme-tRNA complex (86), which perhaps occurs in the transition state 
for aminoacylation. It was found that many synthetases not only bind to their cognate 
tRNAs efficiently, but they also bind to some noncognate tRNAs with appreciably high 
binding affinity (101, 102). The binding of a synthetase to noncognate tRNAs does not 
lead to efficient aminoacylation of the tRNAs presumably because of the discrimination 
step after the first binding step. An important feature of tRNA recognition by synthetase 
is that discrimination against noncognate tRNAs can be achieved at both the binding and 
catalytic steps (5). The studies of numerous cognate and noncognate synthetase-tRNA 
interactions have shown that for some interactions, binding discrimination contributes 
only a 100-fold preference for the cognate tRNAs, while the discrimination against 
noncognate tRNAs at the transition state of catalysis may be as high as 10,000 (89). 
Despite the relatively large number of nucleotides in tRNAs, studies show that only a 
limited number of nucleotides contribute to the specific recognition of tRNAs by 
synthetases. These important nucleotides are called the recognition elements of tRNA. 
The high specificity and efficiency of aminoacylation is achieved by 1) the specific 
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recognition of tRNA by its cognate synthetase, which is governed by the positive identity 
elements on the tRNA molecule that, in most cases, interact directly with synthetase; and 
2) the effective discrimination against noncognate tRNAs, in which negative identity 
elements present in noncognate tRNAs block the productive interactions between the 
tRNAs and the synthetase. These negative determinants can be either the specific 
conformation that noncognate tRNAs adopt to prevent tRNA-synthetase recognition, or 
some nucleotides located on noncognate tRNAs that inhibit proper tRNA-synthetase 
interaction. In many cases, positive identity elements that are important for the 
recognition of a given tRNA by its cognate synthetase are also negative determinants for 
some noncognate synthetases. These negative determinants act to prevent proper 
interaction between noncognate tRNAs and synthetases so that mischarging of tRNAs will 
not occur. 
Because all tRNAs are distinguished by their anticodon, this is the logical place for 
discrimination by aminoacyl tRNA synthetases. Therefore, the anticodon of tRNAs has 
been the target of a number of studies using either the in vitro or the in vivo approach 
(103). So far, studies showed that in E. coll the anticodon is involved in the recognition 
of at least 12 tRNAs by their cognate synthetases, including tRNA^®", tRNA*^", tRNA'^, 
tRNA^S tRNA®", tRNA®y, tRNA^", tRNA^>'^ tRNA^"®, tRNA"^, tRNA^y', and tRNA'^'^ 
(104). A series of experiments by Schulman and coworkers have established that all 
three anticodon nucleotides are critical sites in the E. colt methionine tRNA synthetase 
system both in vitro and in vivo (105, 106). While in most cases base modification of 
nucleotides in the anticodon is not essential for the recognition of tRNAs by their cognate 
synthetases, it was found that in the case of E. coli tRNA"' it is the modified base, 
lysidine, a derivative of cytidine, that is recognized by isoleucine tRNA synthetase and 
prevents this tRNA from being recognized by methionine tRNA synthetase and 
mischarged with methionine (107). It was also found that in the case of yeast tRNA'^, 
the modified anticodon base, m^Gs,, is recognized directly by its cognate synthetase and 
acts as a negative determinant to block productive interaction between this tRNA and 
argininyl-tRNA synthetase, so that mischarging of tRNA"^ by arginine does not occur 
(108). 
How do anticodon bases contribute to tRNA identity? It was found that one or more 
anticodon bases of many tRNAs contribute substantially to the catalytic efficiency (O 
and binding (KJ of these tRNAs to synthetases during aminoacylation (109, 110). 
Biochemical studies of tRNA-synthetase complexes suggest conformational changes in the 
anticodon of tRNAs during aminoacylation (111, 112). X-ray crystal structure studies of 
E. coli tRNA®'°-GlnRS and yeast tRNA^-AspRS complexes show large conformational 
changes in the anticodon loop of the tRNAs as a result of tRNA-synthetase interaction. 
Since the anticodon is an important identity site in many tRNAs, it is believed that the 
recognition of anticodon determinants must be transmitted to the enzyme's catalytic site, 
about 80A away from the anticodon of tRNA, by conformational changes of the tRNA, 
the synthetase or both. Therefore, induction of the proper conformational changes in the 
anticodon of tRNA seems to be one of the major consequences of many cognate tRNA-
synthetase recognition processes (62, 83, 85, 113). This kind of conformational change 
does not occur in noncognate tRNA-synthetase interactions. 
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Beside the anticodon, the region of tRNA structure most frequently implicated in 
synthetase recognition is the domain adjacent to the 3'-terminal CCA end of tRNA, 
including the first 3 base pairs of the acceptor stem (positions 1-72, 2-71, 3-70), In 
many cases, the fourth base from the 3' terminal A, the discriminator base at position 73, 
is also found to be an identity element. The acceptor stem contains major identity 
elements for several tRNAs, including E. coli tRNA'^, tRNA®", and tRNA""®, none of 
which contains identity elements in the anticodon loop region. The G3-U70 base pair is 
found to be an important identity element of tRNA'^ (96, 114, 115). It was found that a 
minihelix containing either the acceptor stem plus T-stem and loop structure or a 
microhelix containing only the acceptor stem of tRNA'^ can be efficiently ammoacylated 
with alanine (116). Experunents provide strong genetic and biochemical evidence that 
tRNA^ identity depends not only on direct recognition of the G3-U70 base pair, but also 
on the helix deformability associated with this wobble base pair (96, 114, 115, 116). 
Other studies showed that the first three base pairs in the acceptor stem of tRNA®" and 
the discriminator base are important identity elements of this tRNA (117). tRNA^" is 
unique among E. coli tRNAs in having an extended acceptor stem beyond the first base 
pair, 1-72, and as a result, this tRNA contains 8 base pairs in its acceptor stem. The 
first base pair in its acceptor stem, -1G-C73, is important for the aminoacylation of this 
tRNA (118). A number of smdies suggested that many other tRNAs also contain 
recognition elements in their acceptor stems cind discriminator base positions, including 
E. coli tRNA^®', tRNA®", tRNA®^, tRNA""", and tRNA^, although these recognition 
elements are not as critical as those found in tRNA'^', tRNA®" and tRNA®' (5). 
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In addition to the acceptor stem and the discriminator base which play significant, in 
some cases, crucial roles in synthetase recognition, another region of the tRNA, the 
variable pocket, is also found to be important for some tRNAs. In the three dunensional 
structure of tRNA, nucleotides at positions 16, 17, 20, 59 and 60 form a patch or 
"variable pocket" that arches out from the surface of the tRNA (119). The 
distinctiveness of the variable pocket led to a suggestion that it is part of a synthetase 
recognition system for discriminating among tRNAs. The best-known examples of 
recognition sites in the variable pocket are E. coli tRNA'"'®, yeast tRNA"", and E. coli 
tRNA^ (104). In E. coli tRNA^®, it was found that nucleotides at positions 20, 59 and 
60 are involved in recognition by PheRS. In contrast, only position 20 was found to be 
involved in the recognition of yeast tRNA^® and E. coli tRNA^ by their synthetases. 
Finally, not only does the specific recognition of a tRNA by its cognate synthetase 
play an important role in the aminoacylation specificity of the tRNA, but the effective 
discrimination of noncognate tRNAs by synthetases also plays an important role in 
preventing mischarging of tRNA. Whereas positive recognition elements present in a 
tRNA are important for the cognate tRNA-synthetase interaction, negative determinants 
present in noncognate tRNAs act to block the productive interaction between the 
noncognate tRNA and synthetase. These negative determinants may be linked to the 
presence of a modified base (as mentioned above in the cases of E. coli tRNA°® and 
tRNA'^'''), or to conformational features present in noncognate tRNAs, or just to the 
occurence of canonical nucleotides at specific sites ±at act as blocking elements. Study 
of both of the positive and negative identity elements of tRNAs can help us understand in 
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depth the mechanism of tRNA-synthetase recognition that leads to the high specificity of 
aminoacylation. 
Study of the Recognition Elements of E. coli tRNA^*  ^
The role of the anticodon of tRNA^** in valyl-tRNA synthetase (VRS) recognition has 
been extensively studied. Schulman and Pelka (106) substituted the anticodon of tRNA'^" 
(CAU) with that of tRNA^*' (UAC) and showed that the tRNA^" variant became a much 
better substrate for VRS, although this tRNA retains only 10% valine-charging activity 
compared to wild type tRNA^*". This suggests that the anticodon of tRNA^"' is an 
important, but perhaps not the only identity element of tRNA^''. We reached the same 
conclusion (120) and identified the anticodon bases A35 and C36 as very important 
recognition elements of tRNA^*'. Besides the anticodon, there are other recognition sites 
in tRNA^®". McClain et al. suggested possible recognition sites of tRNA^** by computer 
analysis of 67 E. coli tRNA sequences (121, 122), and proposed that the anticodon bases 
A35 and C36, the base pah* U4-A69 in the acceptor stem, the base pair C30-G40 in the 
anticodon stem, and 044 in the variable loop are possible identity elements of tRNA^®'. 
The U4-A69 base pair itself, or the region near the 4-69 position in the acceptor stem of 
tRNA^®' probably makes contact with VRS during aminoacylation process, as suggested 
by ''F NMR study of (FUra)tRNA^*'-synthetase complex (62), and by tRNA footprinting 
studies (123). Recently, Tamura and coworkers reported (124) that changing the 
discriminator base A73 to G, and especially to U decreases the aminoacylation activity of 
tRNA^®' significantly, suggesting that the discriminator base may be a recognition site of 
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tRNA^*^. They also showed that the relative aminoacylation efficiency of the 
tRNA^*' mutant containing A4-U69 is reduced 8-fold compared to that of wild type 
tRNA^** with U4-A69, and the V^/K„ of another tRNA^®" mutant C3-G70 is reduced 2-
fold compared to that of wild type tRNA^** containing G3-C70. They concluded that the 
discriminator base A73, the base pairs U4-A69 and G3-C70 are identity elements of E. 
coli tRNA^"*. Results from our laboratory (Vahid Feiz, unpublished observations), 
however, contradict these conclusions. We found that changing the U4-A69 to C4-G69 
does not reduce the aminoacylation activity of the tRNA significandy. However, a 
tRNA^®" mutant containing a U4-G69 wobble base pair has a relative aminoacylation 
efficiency value of only 0.19 compared to that of wild type tRNA^"^. These 
conflicting results need to be resolved. 
Our laboratory has been using the in vitro approach, originally introduced by 
Uhlenbeck and coworkers (17), to study the recognition of tRNA'^'^by valyl-tRNA 
synthetase (VRS). As mentioned above, this method involves the in vitro transcription of 
synthetic tRNA genes by T7 polymerase. By oligonucleotide-directed mutagenesis of the 
cloned tRNA gene, tRNAs having any desired sequence changes can be readily obtained. 
The characteristics of these tRNAs as substrates for VRS can be examined in vitro by 
aminoacylation kinetic studies to quantitatively evaluate the specificity of each tRNA^®' 
variant in terms of K„ and Vn^x- We utilize the in vitro runoff transcription procedure 
for our studies because of the high yield of tRNA and the stability of the tRNA 
generated. Moreover, the incorporation of 5-fluorouraciI (FUra) as a substitution for 
UTP into the tRNA molecule by the in vitro approach makes it easy to obtain a large 
quantity of 5-fluorouracil-substituted tRNA^*' for structural studies by "F NMR. Our 
laboratory has explored the use of NMR of (FUra)tRNA^®' to monitor the 
conformational changes in tRNA, to study the specific interaction between tRNA^"* and 
VRS, and to study the effect of mutations on tRNA structure (see previous discussion). 
Recendy, the ''F NMR spectrum of (FUra)tRNA'^"' has been completely assigned (50, 66, 
125, 139), makmg it easy to monitor conformational changes of the molecule, and to 
study the interaction between tRNA^"'and VRS by "F NMR spectroscopy (62). 
NMR Study of the Recognition of fFUra^tRNA^** bv Valvl-tRNA Synthetase 
The high sensitivity to detection (83.3% that of 'H), 100% natural abundance, large 
chemical shift range, and the extreme sensitivity of "F chemical shifts to the 
environment of the fluorine nucleus make "F NMR a suitable tool to probe protein-
nucleic acid interactions (67), since only the chemical shifts of the fluorine nucleus can be 
observed in the complex without interference from other signals from the protein. 
Information about conformational changes of (FUra)tRNA that result from tRNA-
synthetase interactions can be obtained from ''F NMR study of the tRNA-synthetase 
complex. This information can provide us with knowledge about how tRNA binds to the 
synthetase and what conformational changes occur in the tRNA molecule. "F NMR 
studies of the interaction between E. coli tRNA^"* and its cognate valyl-tRNA synthetase 
(VRS) have been carried out in this laboratory (62). The results show that VRS causes 
marked perturbations in the "F NMR spectrum of (FUra)tRNA^'''. Major changes in the 
^'F NMR spectrum of (FUra)tRNA^'' upon addition of VRS involve FU34 at the 5' 
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position of the anticodon, FU7 and FU67 at the bottom of the acceptor stem, all of which 
are situated along the bend on the inside of the L-shaped tRNA molecule, extending from 
the acceptor stem to the anticodon (50). VRS binding has litde effect on fluorine 
residues located on the opposite side of the tRNA molecule. These results suggest that 
VRS binds to tRNA^*^ molecule along the inside of the L-shaped structure from the 
acceptor stem to the anticodon loop, which is consistent with the tRNA-synthetase 
interaction model proposed by Rich and Schimmel (68) (Figure 4). 
Figure 4. A proposed model of the interaction of tRNA with the surface of synthetase 
(Rich and Schimmel, 1977). The tRNA molecule shown here is based on the 
three dimensional structure of yeast tRNA'''". The dashed lines (A-C) represent 
three different synthetase surfaces in contact with different sizes of 
recognition region of tRNA. 
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EXPERIMENTAL PROCEDURES 
Materials 
Bacterial Strains. Phape Strains, and Plasmids 
E. coli TGI (K12, [lac-pro], SupE, thi, hsdD5/F'traD36, proA+B+, lacP, lacZ 
Ml5), obtained from Amersham inc., was used for transformation by phagemid DNA 
carrying tRNA genes. Bacteriophage M13K07 and phagemid pUC119 were gifts from 
Dr. Alan Myers (Iowa State University). Phagemid pVAL119 is a derivative of pUC119 
which contains a T7 promoter directly followed by a tRNA^*'gene (50). Phagemid 
pFVAL119 is a derivative of pVAL119 which has a Fokl restriction site inserted 
downstream of the tRNA^®* gene. Phagemid pALA119 is a derivative of pUC119 which 
contains a T7 promoter and a tRNA'^ (anticodon UGC) gene, Phagemid pFPHE119 is a 
derivative of pUC119 containing a T7 promoter followed directly by a tRNA^*"® 
(anticodon GAA) gene and a Fok I restriction site. 
Restriction Endonudeases and Other Enzvmes 
Restriction endonudeases were obtained from New England Biolabs, Bethesda 
Research Laboratories or Allied Biochemical and were used according to the 
manufacturer's instructions. Inorganic pyrophosphatase and T4 DNA ligase were 
purchased from Boehringer Mannheim Biochemicals. T4 RNA ligase was from 
Pharmacia Biochemicals. Polynucleotide kinase was from Bethesda Research 
41 
Laboratories. E. coli S-100 was prepared according to Muench and Berg (126) to 
remove tRNAs and nucleases. Alanyl-tRNA synthetase was a gift from Dr. Paul 
Schimmel (Massachusetts Institute of Technology). Valyl-tRNA synthetase (VRS) was 
purified by Dr. Wen Chy-Chu from E. coli strain GRB238 carrying the plasmid pHOVl 
(62). The bacterial strain was kindly provided by Dr. George L. Marchin (Kansas State 
University). T7 RNA polymerase was prepared from E. coli BL21/pAR1219 (127) 
according to the method of Zawadzki and Gross (128). 
Nucleic Acids and Nucleotides 
Native E. coli tRNA^*^ was purchased from Subriden RNA. Crude unfractionated E. 
coli tRNA was obtained from Plenum Scientific Research Inc. All the nucleotide 
triphosphates used for transcription, with the exception of FUTP, were purchased from 
United State Biochemical Co. FUTP was obtamed from Sierra Bioresearch and 5'-GMP 
was from Sigma. Deoxyoligonucleotides were synthesized and HPLC purified by the 
Nucleic Acid Facility at Iowa State University. The synthesis was performed on a 
Biosearch 8750 DNA synthesizer. 
Radioisotopes 
["C]valine (158 Ci/mole, 1(K) /^Ci/ml) was bought from ICN Biomedicals. pH]valine 
(32 Ci/mmole, ICi/ml), pH]alanine (50Ci/mmole, ICi/ml), |^H]glycine (19 Ci/mmole, 
ICi/ml), pHjglutamic acid (45 Ci/mmole, ICi/ml), ["C]threonine (241 Ci/mmole, 
O.lCi/ml) and deoxyadenosine 5'-a-PS]thiotriphophate were all purchased from 
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Amersham Inc. [7-^^P]ATP (SOOOCi/mmole, lOmCi/ml) was from New England Nuclear 
Research. Radioactive [5'-^^P]pCp was prepared from [7-^^P]ATP and 3'-CMP according 
to England et al. (129). A 50 /tl reaction mixture containing ImM 3'-CMP, 25mM 
potassium-CHES pH 9.5, 50 /Lcg/ml BSA, 3mM DTT, 5mM MgClj, 5/iiM [7-^^P]ATP and 
10 units of T4 polynucleotide kinase was incubated at 37°C for 90 minutes. The product 
of this reaction was analyzed by thin-layer chromatography (TLC) on polyethyleneimine 
plates (Macherey-Nagel Co.) developed with 0.8 M anmionium sulfate. Almost all of ±e 
radioactive material was found to be converted to [5'-^^P]pCp. The product was stored at 
-20°C and used directly for 3'-end labeling of tRNA. 
Miscellaneous 
RNase-free BSA was purchased from Boehringer Mannheim Biochemicals. 
Ampicillin, kanamycin, spermidine, tris [hydroxymethyl]-aminomethane, urea, sodium 
cacodylate, agarose were all from Sigma. Acrylamide and N,N-methylene bisacrylamide 
were also bought from Sigma and were purified by stirring a 40% solution with mixed-
bedresin MB-3 overnight as described by Maniatis (130). HPLC grade ammonium 
acetate and methanol were purchased from Fisher Scientific. 20 x 20 cm cellulose thin-
layer plate, 0.1 mm, was from Merck, West Germany, # 5577. Ingradients for cell 
growth media were perchased from Difco or Fisher Chemical Co. Whatman 3 MM 
paper was from Whatman, Hillsboro, OR. 
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Methods 
Construction of pFVALllP Recombinant Phapemid 
Phagemid pFVALl 19 is a derivative of pVALl 19, Construction of the recombinant 
phagemid pVAL119, which contains an upstream T7 promoter and a downstream E. coli 
tRNA^"^ gene, was previously described (50). Phagemid pFVAL119 was constructed by 
ligating overlapping oligonucleotides, pGATCCAGTCATCCA and 
pGATCTGGATGACTG, containing the Fokl recognition sequence, synthesized by the 
Nucleic Acid Facility of Iowa State University, into the BarnUl site of pVAL119. The 
two Fok I-containing DNA oligonucleotides were annealed together by incubation at 40°C 
for 30 minutes, followed by incubation at 37° C for an additional two hours. The 
annealed DNA fragments were 5'-phosphorylated in a 300 ii\ reaction mixture containing 
approximately 8.65 nmol DNA fragments, 70 mM Tris-HCl, pH7.6, 10 mM MgCla, 5 
mM DTT, 0.1 mM ATP and 30 units of T4 polynucleotide kinase. After incubation at 
3TC for one hour, phenol was added to remove kinase, followed by ether extraction and 
ethanol precipitation of the phosphorylated DNA fragments. To prepare the vector, 
plasmid pUC119 was digested with BamHI at 37°C for two hours. The digested DNA 
fragment was purified by electrophoresis on a 1 % agarose gel and recovered by 
electroelution (130). The vector was then dephosphorylated by incubating with 12 units 
of CIP, followed by phenol treatment to remove CIP, and ethanol precipitation, and was 
finally dissolved in TE buffer. The large DNA fragment (vector) was then incubated 
with the phosphorylated FoM-containing DNA fragments in a 20 ix\ reaction mixture 
containing 2.5 units of T4 DNA ligase at 16°C for overnight. The ligation mixture was 
then used to transform E. coli TGI cells. The resultant phagemid, pFVALl 19, was 
selected and its sequence confirmed by the dideoxy DNA sequencing procedure (131), 
Figure 5 shows the scheme used to construct phagemid pFVALl 19. 
Construction of Phagemid pFALA119 
To construct the phagemid pFALA119, which contains a wild type tRNA'^ gene and 
a downstream Fokl site, recombinant phagemid pALAl 19-03 containing the wild type 
tRNA'^ gene (132), was digested with restriction enzymes EcoRl and BarnRl at 3TC for 
two hours. The restricted small DNA fragment containing a tRNA^ gene was purified 
by 8% polyacrylamide gel electrophoresis (130). To prepare the vector, phagemid 
pFVALl 19 was digested with EcdKl and BamUl, and the large DNA fragment was 
isolated by 1 % agarose gel electrophoresis in the same way as described for construction 
of phagemid pFVALl 19. The purified insert containing the tRNA'^ gene was ligated to 
die purified vector in a reaction containing T4 DNA ligase at IS^C overnight. The 
ligation mixture was used directly to transform E. coli TGI cells. The sequence of 
phagemid pFALAl 19, isolated firom the transformats, was confirmed by dideoxy DNA 
sequencing. 
Construction of Phagemid pFPHE119 
Plasmid pUS618, a derivative of pUClS which contains the E. coli tRNA^' gene, 
was a gift of Dr. Olke C. Uhlenbeck (Univ. of Colorado, Boulder). To prepare 
Figure 5. Construction of phagemid pFVAL119 containing the E. coli tRNA^®' gene, linked directed to an upstream T7 
promoter, and a Fok I site appropriately positioned to cleave the phagemid DNA so as to yield a template for in 
vitro runoff transcription of RNA with any desired 3' terminus. 
EcoRl T7 promoter BamHI 
_l tRNA^"' gene i 
-GAATTCCTGCAGTAATACGACTCACTATAGGGTG CCACCAGGATCC— 
-CTTAAGGACGTCATTATGCTGAGTGATATCCCAC GGTGGTCCTAGG— 
t 
nVAL119 BstNI 
BamHI i 
+ 
pGATCCAGTCATCCA 
GTCAGTAGGTCTAGp 
T4 DNA Ligase i 
•1^  OS 
OooRI T7 promoter Fokl BamHI 
_i tRNA^"' pene I i 
--GAATTCCTGCAGTAATACGACTCACTATAGGGTG CCACCAGGATCCAGTCATCCAGATCC-
-CTrAAGGACGTCATTATGCTGACTGATATCCCAC GGTGGTCCTAGGTCAGTAGGTCTAGG-
t Fokl 
Fokl or recognition site 
nVAIJ 19/F BstNI 
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phagemid pFPHE119, recombinant pUS618 plasmid containing a tRNA"" gene was 
digested with SamHI and Pst 1. The tRNA"*' containing inserts was isolated by gel 
electrophoresis on 8% polyacrylamide gels. The DNA band corresponding to the insert 
was cut from the gel and purified by elution of the DNA fragments with DNA soacking 
solution (130). To prepare the small DNA fragment containing a Fok I restriction site, 
the phagemid pFVAL119 was digested with BamVil and Hind III and the Fok I-containing 
fragment was then isolated by 8% polyacrylamide electrophoresis and purified as 
described above. To prepare the vector, phagemid pUC119 was digested with Pst I and 
Hind III. The lagre DNA fragment was purified by electrophoresis on a 1 % agarose gel 
and recovered using the SpinBind DNA Recovery System (Amersham). The tRNA^®-
gene-containing fragment was ligated to the FoM-containing fragment and the vector with 
T4 DNA ligase at 16°C overnight. The sequence of the recombinant phagemid containing 
the tRNA"" genes and the Fokl restriction site was confirmed by the dideoxy DNA 
sequencing method (131). 
Single-Stranded DNA Preparation 
Single stranded DNA templates for DNA sequencing and oligonucleotide-directed 
mutagenesis were prepared using the helper phage M13K07, as described by Viera and 
Messing (130). Ten ml of 2 x YT media containing 40 /ng/ml ampicillin was inoculated 
with TGI cells carrying the recombinant phagemid. The culture was allowed to grow to 
early log phase (approximately 30 minutes at 37°C with moderate shaking), and was then 
infected with M13K07 at a multiplicity of infection of 2-10. Following an additional 30 
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minutes of incubation under the same conditions, the culture was diluted approximately 
ten times with fresh 2 x YT media containing 40 /xg/ml ampicillin and 70 jug/ml 
kanamycm, and the cells were allowed to grow for 14-16 hours at 37°C. The culture was 
then centrifiiged in a Beckman JA-20 rotor at lOK rpm, 4°C, for 10 min. The 
supernatant was collected and recentrifuged to remove any remaining cells. Phage 
particles were precipitated from the supernatant by addition of 0.2 ml 20% polyethylene 
glycol-2.5 M NaCl for every milliliter of solution, followed by incubation on ice for 15 
minutes. The sample was then centrifiiged at 12K rpm, 4°C, in a JA-20 Beckman rotor 
for 15 minutes. The supernatant was discarded and the pellet was resuspended in 300 jA 
of TE buffer (10 mM Tris-HCl pH 7.4, 1 mM EDTA, pH 8.0). The suspension was 
then treated twice with an equal volume of phenol/chloroform/isoamyl alcohol (25:24:1), 
followed by an extraction with chloroform/isoamyl alcohol (24:1). DNA was ethanol 
precipitated and dissolved in 20 fd of water. The purity of the sample was checked by 
1 % agarose gel electrophoresis. The yield of this preparation is usually 30-40 fig of 
DNA per 10 ml of cell culture. For sequence analysis, DNA was prepared from 1.5 ml 
of cell culture using the same procedure. 
Oligonucleotide-Directed Mutagenesis 
Oligonucleotide-directed mutagenesis of E. coli tRNA genes was performed by the 
method of Eckstein (133) using the oligonucleotide directed mutagenesis kit from 
Amersham Inc (#RPN 2322). All mutagenic oligonucleotides used in making tRNA 
mutants were synthesized and HPLC pxirified by the Nucleic Acid Facility at Iowa State 
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University. Mutants were selected by dideoxy DNA sequencing (131). 
In vitro Transrription of tRNA Genes 
All the recombinant plasmids used for in vitro transcription were purified by cesium 
chloride density gradient ultracentrifugation (130). Purified plasmids were digested with 
Bst NI or Fok I to generate a linear template that contains the T7 promoter followed by 
the coding sequence of tRNA gene terminating in the 3' sequence GGT that corresponds 
to the 3' CCA end of the transcribed tRNA. Restriction enzymes were removed by 
phenol extraction and DNA templates were recovered by ethanol precipitation. 
Transcription was carried out as described by Sampson and Uhlenbeck (17) in a 
reaction mixture containing: 40 mM Tris-HCl pH 8.0, 22 mM MgClj, 2 mM spermidine, 
5 mM DTT, 50 /Mg/ml BSA, 80 uglml jBj?NI or Fok I digested plasmid, 4 mM of each of 
the nucleotide triphosphates ATP, CTP, GTP, UTP or FUTP (when 5-fluorouracil-
substituted tRNA was transcribed), 160 mM GMP, 80 units//il of T7 RNA polymerase, 
and 4 units/ml of inorganic pyrophosphatase. After incubation for 2 hours at 42''C, the 
reaction mixture was extracted twice witii an equal volume of phenol/chloroform/isoamyl 
alcohol (25:24:1), followed by one extraction witii chloroform/isoamyl alcohol (24:1). 
Transcription products were then precipitated with ethanol and the pellet was recovered 
by centrifugation, dried and dissolved in TM2 buffer (Tris-acetate pH 7.4, 15 mM 
magnesium acetate). 
50 
HPLC Purification of in vitro tRNA Transpripts 
Transfer RNA transcripts were purified by HPLC using a Beckman HPLC system 
with two model HOB pumps, a model 406 analog interface module and a model 116 
programmable detector. The HPLC system utilized System Gold Chromatography 
Software written by Beckman Instruments, Inc. (#23952). 
In the first step, the sample was chromatographed on a Toyopearl DEAE-650S 
column (250x4.6 mm) to remove unincorporated nucleotide triphosphates and template 
DNA. The column was initially equilibrated with a buffer containing 25 mM Tris-HCl, 
pH 7.4 and 250 mM NaCl. After injection of the transcription products, the column was 
washed with 350 mM NaCl in the same buffer, and tRNA was eluted with a linear 
gradient of NaCl from 350 mM to 600 mM (0,5 ml/min, 40 minutes). A typical 
chromatogram shows a UV absorbing peak that contains free 5'-nucleotide triphosphates, 
followed by a second peak that contains the tRNA transcript. A third small peak or a 
shoulder containing the DNA template is then eluted. Material from a 1 ml of 
transcription reaction can be applied to the column. The tRNA-containing fractions were 
pooled and ethanol precipitated. The tRNA pellet was then dissolved in 1 ml of 1.0 M 
NH4(0Ac) pH 6.0, 20 mM MgClj. 
Further purification of the tRNA transcript was carried out by HPLC on a Vydac C4-
reverse phase column (250x4.6 mm). The column was first equilibrated with 100% 
buffer A (1.0 M NH4(0Ac) pH 6.0, 20 mM MgCy and 0% buffer B (10 mM 
NH4(0Ac), 20 mM MgClj, 10% methanol). After injection of the sample, the column 
was washed for an addhional 15 minutes with buffer A. tRNA was eluted with a linear 
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gradient of 100% buffer A, 0% buffer B, to 50% buffer A, 50% buffer B (0.5 ml/min, 
60 minutes). The tRNA-containing peak was collected and the tRNA sample was 
precipitated with three volumes of 95 % ethanol. The tRNA was then washed once with 
70% etiianol to remove remaining salts. Finally, the tRNA sample was dried m a speed-
vacuum drier and dissolved in TMj buffer. 
Aminoacvlation Plateau Charging Assay 
Plateau levels of aminoacylation of purified tRNA^®" transcripts were determined at 
37°C in a 65 fil reaction mixture containing; 100 mM HEPES pH 7.5, 10 mM KCl, 15 
mM MgCl2, 7 mM ATP, 1 mM DTT, 99 /xM pH]Valine (5.05 Ci/mmole), 0.05-0.1 Ajgo 
of the HPLC purified tRNA^*", and an excess of VRS (>0.01 ngfiA). Ten fd aliquots, 
taken at different incubation times up to 60 minutes, were spotted onto a 3 MM filter 
paper strip that was presoaked in 10% trichloroacetic acid to stop the reaction. After the 
last sample was spotted, the paper strip was washed first with 5% TCA, three times, then 
with 95% ethanol, twice, as described by Bruce and Uhlenbeck (93). Samples were 
counted for 1 minute in a Beckman LS-IOOC Scintillation counter or a Tm Analytic j8-
trac counter in a Bio-Safe NA scintillation counting cocktail (Research Products 
International). 
Aminoacylation levels of tRNA'^ transcripts were determined at 37°C, in a 60 nl 
reaction mixture containing: 150 mM potassium phosphate at pH 7.5, 10 mM MgClj, 20 
mM DTT, 4 mM ATP, 0.1 mg/ml BSA, 4 units of pyrophosphatase, 43 iiM pH]alanine, 
and crude ARS (5/xg//al) (134). Ten ^1 aliquots were taken at different time points and 
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prepared for measurement of radioactivity as described for aminoacylation with valine. 
Aminnapvlfltlnn Kinetics of tRNA Variants 
Kinetics of aminoacylation with valine were measured at 37°C in a reaction mixture 
containing: 100 mM HEPES, pH 7.5, 15 mM MgCla, 7 mM ATP, 1 mM DTT, and 99 
/xM pH]valine (5Ci/mmol, firom Amersham, Arlington Heights, IL). Transfer RNA 
concentrations ranged from 0.3 /xM to 5.0 /xM and were determined by measuring 
maximal valine acceptance (plateau) levels. Reactions were initiated by adding 1 nM 
purified valyl-tRNA synthetase (VRS). Ten jtil were removed at 30-s intervals, spotted 
on Whatman 3 MM paper (Whatman, Hillsboro, OR), and processed as described above 
(93). Km and values were determined by a least-square fit of the double-reciprocal 
plot of the data using the Enzfitter computer program (for non-linear regression analysis). 
The K„ and values for each mutant were obtained from at least two independent 
preparations of transcripts, which showed good reproducibility (values were reproducible 
to ±10-25%, depending on different mutants studied). 
Kinetics of aminoacylation with alanine were measured at 37°C in reaction mixtures 
containing: 60 mM potassium phosphate, pH 7.5, 10 mM MgClz, 2 mM ATP, 2 mM 
DTT, and 28 /xM pH]alanine (5Ci/mmol, from Amersham, Arlington Heights, IL) (134). 
Transfer RNA concentrations ranged from 0.5 - 6.0 ^M, determined by measuring 
maximal alanine acceptance (plateau) levels. Reactions were initiated by adding 15 nM 
purified alanyl-tRNA synthetase (AlaRS), kindly provided by Dr. Paul Schimmel from 
Massachusetts Technology of Institute (MIT). Samples were taken and processed as 
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described for the reaction with valine. 
Purification of Bacterial Phase T7 RNA Polymerase 
The purification of bacterial phage T7 RNA polymerase was performed according to 
the method of Zawadzki and Gross (128). The purification started with about 10 g of 
wet cell. About 40-60 mg of purified T7 RNA polymerase was finally obtained, and was 
shown to contain only a single band by SDS-polyacrylamide gel electrophoresis. 
3'-End Group Analysis of in vitrn Transcribed tRNA 
In Vitro transcribed tRNA^®* was purified on a C4 HPLC column as described before. 
3'-End labeled tRNA was prepared by reaction with [5'-^^P]pCp and T4 RNA ligase 
(129). Labeled tRNA was purified by electrophoresis on a 15% polyacrylamide/8 M 
urea gel (150 x 200 x 1.5 mm) and was recovered firom the gel by crushing and soaking 
the gel at 4°C overnight in elution buffer containing 500 mM ammonium acetate, 0.1 % 
SDS, 0.001% Triton X-100 and 40 /xg/ml unlabeled carrier tRNA (135). The 3'-terminal 
residues of the in vitro transcripts were determined by thin layer chromatography of 
RNase T2 digests of the end-labeled tRNA. RNase T2 digestion of 3'-end labeled tRNA 
was carried out in a 5 /xl reaction mixture containing 20 mM ammonium acetate, pH 4.5, 
and 0.1 units of RNase T2. Incubation time was 2.5 hours at 37°C. Two-dimensional 
thin layer chromatography (TLC) was used to analyze the nuclease digests. The RNase 
hydrolyzate, to which a mixture of unlabeled 3' nucleoside monophosphates (0.2 A jm 
units each) was added as markers, was applied to a 20 x 20 cm cellulose thin layer plate 
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(0.1 mm thick, Merck, #5527). The chromatogram was developed in the first dimension, 
at room temperature, with isobutyric acid : 0.5 M ammonium hydroxide (5:3 (v/v)), until 
the solvent front reached the top of the plate. After drying, the plate was developed in 
the second dimension with isopropanol : concentrated HCl : water (70:15:15 (v/v/v)). 
Marker compounds were visualized under a UV lamp and '^P-labeled nucleotides were 
located by autoradiography using Kodak diagnostic film (X-OMAT™AR); the exposure 
time was about 30 minutes. Radioactive spots were excised from the plate, placed in 
vials (containing no scintillation fluid), and the amount of radioactivity was determined by 
counting in a Tm Analytic |8-trac scintillation counter for one minute. 
Isolation and Identification of Cvtidvl-Valine 
Aminoacylation of 4.0 mg of HPLC purified mutant C76 tRNA'^'^, was carried out at 
37°C in a reaction mkture containing 100 mM HEPES, pH 7.5, 10 mM ATP, 10 mM 
KCl, 1 mM DTT, 30 mM MgClj, 99 /tM pHJvaline (5Ci/mmol, Amersham, Arlington 
Heights, IL) and 25 fig purified VRS. Ten /il Aliquots were taken from die reaction 
mixture at 40, 60, and 80 minutes, spotted on TCA-soaked Whatman 3 MM paper, 
washed 4 times with 5 % TCA, dried, and counted m order to follow the time course of 
the reaction. When the plateau charging level of aminoacylation was reached, 
approximately 1300 pmol/Aja, the reaction was stopped by addition of an equal volume 
of phenol/chloroform/isoamyl alcohol (25:24:1). The mixture was then extracted once 
with chloroform/isoamyl alcohol (24:1). Aminoacylated tRNA was precipitated with 
ethanol, and die pellet washed with 70% ethanol, dried, and dissolved in 0.5 ml 20 mM 
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triethylammonium formate, pH 4.6. The sample was then loaded onto a column of 
Sephadex G-25 (coarse grade, 30 ml bed volume; Pharmacia, Inc.) that had been 
previously equilibrated with the same buffer (136). Elution with the same buffer yielded 
aminoacyl-tRNA freed of low molecule weight contaminants including radioactive valine. 
The elution product was recovered by ethanol precipitation, followed by washing once 
with 70% ethanol, and was dissolved in 20 mM triethylammonium formate, pH 4.6. By 
measuring the absorbance of the product at 260 nm and the radioactivity of the sample, it 
was found that negligible deacylation occurred during the purification process. 
The valyl ester of the terminal nucleoside was prepared from the purified valyl-tRNA 
by pancreatic ribonuclease A digestion, followed by chromatography of the products on a 
DEAE-cellulose column developed with triethylammonium formate buffer, pH 4.6, to 
isolate the aminoacyl-nucleoside (136). Briefly, aminoacyl-tRNA mutant C76 (4 mg), 
valylated and purified as described above, was redissolved in 20 mM triethylammonium 
formate, pH 4.6, and was incubated for 30 minutes at room temperature with 50 ng 
RNase A (Sigma). The reaction mixture was then immediately applied to a column of 
DEAE-32 cellulose (10 ml volume bed, Whatman, Hillsboro, OR) pre-equilibrated with 
the same buffer. The aminoacylnucleoside and the radioactivity emerged between 5.5 ml 
and 8.5 ml of elution buffer. Free nucleosides were eluted between 10 ml and 14 ml and 
did not contain radioactivity. The five peak fractions (0.5 ml each) from the first peak 
were pooled and concentrated to a volume of 0.5 ml (see below). The UV spectrum of 
the pooled sample was measured. Fractions from the second peak were analyzed 
similarly by UV spectroscopy. 
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The 0.5 ml pooled sample was then dried down completely, dissolved in 1.5 M 
triethylammonium bicarbonate, pH 9.5, and incubated at 37°C for 30 minutes to 
hydrolyze the aminoacyl ester bond. It was then lyophilized to dryness and the residue 
was dissolved in 500 /xl 0.4 M Tris:HCl, pH 7.0. The UV spectrum of this sample was 
recorded. 
Preparation and Purification of Tipht E. coli 70S Ribosome 
This procedure was obtained from Dr. Ofengand and is based on the method of 
Pestka and Erbe (137,138). Eight grams of wet E.coli B cells were thawed at 4''C, 
mixed with 16 grams of Alumina (Sigma), and ground in a mortar at 4°C to prepare a 
paste. For every 8 grams of cells, 0.15 ml of DNAse I (1 mg/ml, RNAase free) was 
added, and the mixture was incubated at 4°C for 10 minutes. Thirty ml of buffer A 
containing 20 mM Hepes pH 7.5, 10.5 mM Mg(0Ac)2, 0.5 mM EDTA, 60 mM NH4CI, 
10 mM 2-mercaptoethanol was added, and the suspension was centrifuged at 10 K rpm 
for 10 minutes in a JA-20 rotor, at 4''C. The supernatant was saved. The pellet was 
mixed with 5 ml buffer A, and again centrifuged at 10 K rpm for 10 minutes in a JA-20 
rotor at 4°C. The supernatants were combined and centrifuged at 17 K rpm for 40 
minutes in a JA-20 rotor at 4°C. The resulting supernatant was carefully layered on 
buffer B (20 mM Hepes pH 7.5, 10.5 mM Mg(0Ac)2, 0.5 mM EDTA, 0.5 M NH4CI, 10 
mM 2-mercaptoethanol, 1.1 M sucrose) in a 25 ml centrifuge tube and ribosomes were 
pelleted by centrifugation at 40 K rpm for 13 hours in a Ti 70 rotor. The pellets were 
resuspended in 2 ml buffer A, and the suspension was clarified by centrifugation at 20 K 
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rpm for 15 minutes to remove aggregates. Purified 70S ribosomes were obtained by 
washing the crude ribosomes twice with 1 M NH4CI. To do so, the crude ribosome 
pellet was suspended in 1 M NH4CI in 10 mM Tris:HCl, pH 7.8, 10 mM MgCl2 and 1 
mM 2-mercaptoethanol. The suspension was incubated at 4®C for 12 hours with gentle 
stirring, then clarified by low speed centrifiigation at 10 K rpm in a JA-20 rotor at 4''C. 
Ribosomes were pelleted by centrifiigation at 40K rpm at 4°C for 4 hours in Ti 70 rotor. 
The NH4CI washing procedure was repeated twice. The final pellet of washed ribosomes 
was suspended in buffer A and the Azeo/Ajgo of the purified ribosomes was determined to 
be 1.95. 
In vitro PolvfU.O-Directed fval.phe) Copolvpeptide Synthesis 
Polypeptide synthesis was carried out in a reaction mixture containmg per 100 jxh 50 
mM Bicine, pH 7.5 (Sigma), 50 mM NH4CI, 20 mM Mg(0Ac)2, 3 mM ATP, 1 mM 
DTT, 4 units pyruvate kinase (Sigma), 5 mM phosphoenol pyruvate (Sigma), 1 mM 
GTP, 0.05 mM cold valine, 40 ixg E.coli S-100, 0.73 A260 units of poly(G,U)(3:1) 
(Sigma), 4.2 A2S0 units of NH4Cl-washed ribosomes, and 30 pmol pHJVal-tRNA^®', 96 
pmol of cold yeast tRNA"" (Sigma), and 0.01 mM cold phenylalanine (53). Reactions 
were initiated by addition of 70S ribosomes and the reaction mixture was incubated at 
37°C for the indicated periods of time. The reaction was stopped by adding 4 ml of 5% 
TCA and the mixture was then heated at 95°C for 20 minutes. After coolling the sample 
on ice for 20 minutes, the TCA precipitates were collected on Millipore filters (Millipore 
Corp.) and washed 5 times with 4 ml cold 5% TCA. The filters were dried and the 
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radioactivity of the samples was measured by scintillation counting in a Bio-Safe NA 
counting cocktail (Research Products International Corp.). 
NMR Spectroscopy 
For NMR spectroscopy of (FUra)tRNA^'^, 5-fluorouracil-substituted tRNAs, 
transcribed as described but with FUTP using in place of UTP, were dissolved in 111% 
NMR buffer containing 55.55 mM sodium cocadylate pH 6.0, 16.66 mM MgClz, 111 
mM NaCl and 1.11 mM EDTA. The tRNA was dialyzed against two 250 ml changes of 
the same buffer and the sample volume was adjusted to 300 jul. 10% (v/v) DjO was then 
added to provide an internal lock signal. Before spectra were recorded, transfer RNA 
was renatured by heating at 55°C for 20 minutes followed by slow cooling to room 
temperature. Samples was then transferred to a Wilmad 528PP, 5 mm NMR tube. "F 
NMR spectra were collected at 470 MHz on a Varian Unity 500 spectrometer at the 
temperatures indicated. Data were accumulated by using 12K data points, no relaxation 
delay and a 30 degree excitation pulse. Chemical shifts are reported as ppm from free 5-
fluorouracil. Downfield shifts are indicated as positive numbers. 
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RESULTS 
Structural Requirements for the Recognition of the 3' End of E. coli tRNA^  ^by 
Valyl-tRNA Synthetase; Role of the 3' End of tRNA^®* in Protein Synthesis 
In vitro Synthesis and Function of Wild Type E. coli tRNA^"* Transcribed from the 
tRNA^** Gene Cloned into the Phagemid pFVAL119 
Construction of phap^emid pFVALl 19 containing tRNA^" ^ene 
Because part of the BstNl recognition sequence includes the 3'-CCA end of the tRNA 
gene, mutations introduced into the CCA sequence destroy the BstN I recognition site, 
making it impossible to linearlize the DNA template for runoff transcription. To 
overcome this problem, the recombinant phagemid pFVAL119 was constructed by 
inserting the Fok I recognition sequence into the BamE 1 site of pVAL119 (see Methods). 
The phagemid pFVAL119, like the original phagemid pVAL119, retains the ability to 
package single-stranded plasmid DNA into vu-al particles, after infection with helper 
phage M13K07, for DNA sequence analysis and oligonucleotide-directed mutagenesis. 
Fok I is a class 2 restriction enzyme and its recognition site is 9/13 nucleotides away 
from the cleavage site. Proper positioning of Fok I recognition site down stream of the 
3' end of tRNA gene makes it possible to cleave phagemid DNA with no sequence 
specificity at the cleavage site, permitting transcription of 3' end mutants of tRNA^"'. 
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In vitro transcription of wild type tRNA^** gene cloned into phagemid pFVALl 19 
In vitro transcription of the tRNA^'^gene, cloned into pFVAL119, was performed the 
same way as was done with phagemid pVAL119 (see Methods). The typical yield of 
transcription of wild type tRNA^®* using pFVAL119 phagemid is over 1.0 mg active 
tRNA^"* per ml, which is very close to the yield using pVALl 19. 15% 
polyacrylamide/8M urea gel electrophoresis of the crude tRNA transcript shows that the 
product migrates to the same position as the wild type tRNA^*' transcribed from the 
tRNA^*^ gene cloned into pVAL119 (results not shown). 
Aminoacvlation kinetic studies of wild type tRNA^*' transcribed from phagemid pVAL119 
andpFVAL119 
The activity of wild type tRNA^*' transcribed from pVAL119 restricted with BstN I is 
compared to that of transcripts from pFVAL119 cleaved with either BstN I or Fok I 
(Table 1). 
Wild type tRNA^®* transcribed from the linearlized phagemid pVAL119 or pFVAL119 
have similar valine acceptance levels, 1350-1540 pmol/Ajgo (Table 1), and all the wild 
type tRNA^*^ transcripts exhibit the same aminoacylation efficiency (V^^/KJ within 
experimental error, demonstrating that linearlization of phagemid pFVAL119 with Fok I 
yields DNA templates with the same transcription efficiency as templates derived from 
phagemid pVAL119 cleaved with BstN I. This phagemid has the advantage that the 3'-
CCA end of the tRNA^"" gene can be changed to obtain mutant tRNAs with any desired 
3' end. 
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Table 1. Kinetic parameters for aminoacylation of wild type tRNA^"* transcribed from 
both pFVAL119 and pVAL119 phagemids restricted with either BstN I or Fok I 
restriction enzymes. 
tRNA^®" pmol/A26o K„ V^/K„ Relative 
Variant (jj lM) (/xmole/min/mg) 
A. tRNA^** Transcript from pVAL119 (Lacking a Fok I Site) 
Wild type 1350 1.6 4.8 3.0 (1.0) 
(BstN IT 
B. tRNA^'^ Transcripts from pFVAL119 (Containing a Fok I Site) 
Wild type 
{BstNiy 1540 1.6 5.6 3.5 1.17 
Wild type 
(Fok IT 1390 1.7 4.6 2.7 0.90 
' phagemid DNA linearlized with BstN I 
'' phagemid DNA linearlized with Fok I 
Characterization and Function of 3'-End Variants of tRNA^** 
Identification of the 3'-terminal nucleotides 
tRNA^®* variants with mutations at the 3' terminus were obtained by oligonucleotide-
directed mutagenesis (see Methods). To confirm the identity of the 3' end of tRNA"^"* 
mutant transcripts, 3' end labeled tRNA variants were prepared by reaction with [5'-
^^P]pCp and T4 RNA ligase, purified by electrophoresis on 15% polyacrylamide/8M urea 
gels, and subjected to RNase T2 digestion. The labeled nucleotides were separated by 
two-dimensional TLC. The results (Figure 6). confirm that each tRNA variant has 
predominantly the expected 3' terminal nucleotide; 3' A is found only in wild type 
tRNA^"* (Figure 6A). Because of the known non-template-directed incorporation of one 
or more extra nucleotides during in vitro tRNA transcription by bacterophage T7 RNA 
polymerase (17, 129), some S'-terminal sequence heterogeneity is evident in the tRNA 
transcripts. Seventy-five percent or more of the transcripts terminate in the nucleotide 
expected from the sequence of DNA template; most of the remaining tRNA transcripts 
terminate in C, 
Aminoacvlation of 3'-terminal variants of E. coli tRNA^*^ 
Figure 7 shows the time course of aminoacylation of three mutant transcripts of E. 
coli tRNA^®*, C76, G76 and U76, compared to that of the wild type tRNA transcript. 
Mutant tRNA^®* variants C76 and U76 are readily aminoacylated, with initial rates 40%-
50% that of wild type tRNA^"*. The G76 mutant tRNA^**, however, shows much lower 
charging efficiency compared to the C76 and U76 tRNA^®" variants. The kinetic 
parameters for valine acceptance by in vitro transcribed C76, G76 and U76 tRNA^"^ 
variants are compared to that of wild type tRNA^*' in Table 2. 
Figure 6. Identification of the 3' terminal nucleotides of tRNA^^ variants. The 3'-
terminal nucleotides (Np) in complete RNase T2 hydrolyzates of tRNAs 3'- end 
labeled with 5'-[^^P]pCp by T4 RNA ligase, were separated by two-dimensional 
chromatography on cellulose thin-layer plates. (A) Native tRNA^"' (A76); (B), 
(C), (D), tRNA^®' variants having 3'-terminal C76, U76, and G76, 
respectively. The position of labeled nucleotides was determined by 
autoradiography; unlabeled nucleotide 3'-phosphate markers, visualized by UV 
shadowing, are circled. 
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Figure 7. The time course of aminoacylation with valine of wild type (A76) tRNA^"' 
(open circles) and variants with substitutions at their 3' termini: the U76 variant 
(closed circles), the C76 variant (open triangles), and the G76 variant (closed 
triangles). 
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Table 2. Kinetic parameters for aminoacylation of 3' terminal tRNA™ mutants * 
tRNA™ K. V 
^ xnXK Relative 
Variant (mM) (fimol/mm/mg) Vnux-'Kn, V^/K„ 
Wild type 
transcript 1.4 5.0 3.6 (1.0) 
C76 1.0 1.8 1.8 0.50 
U76 1.9 2.7 1.4 0.39 
G76 0.78 0.017 0.022 6.1x10-' 
® 1 nM VRS and 4 /xM of each tRNA were used in the aminoacylation reaction. 
The relative aminoacylation efficiency (V^/KJ of the C76 and U76 tRNA^®' 
mutants is 40%-50% compared to that of wild type tRNA^®*; Kn, remains essentially 
unchanged, whereas is somewhat decreased. In contrast, the G76 mutant tRNA™, 
although it can be charged to a high plateau level, 1100 pmol/Azgo. is a much poorer 
substrate for VRS; the relative aminoacylation efficiency (V^/KJ of this mutant is 
reduced more than 160 fold compared to wild type tRNA™, due largely to a 300-fold 
decrease in Vn^ (Table 2). To rule out the possibility of 3' end turnover of the mutant 
tRNA variants during aminoacylation, 3' tRNA™ variants were first aminoacylated. 
After hydrolysis of the aminoacyl bond, the 3' end residue of each tRNA variant was 
determined (see Methods). The results were identical to those obtained prior to 
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aminoacylation. 
Isolation of valvl-cvtidine from the tRNA^** mutant C76 
More direct evidence that valine is esterified to a 3' terminal nucleotide of tRNA^"' 
other than adenosine was obtained by isolating and characterizing valyl-cytidine from a 
RNase A digest of aminoacylated C76 tRNA^** mutant. Four mg of mutant C76 tRNA^*^ 
were aminoacylated with pH]valine to a plateau level of about 1100 pmol/Aaso- The 
aminoacylated tRNA was purified (see Methods) and digested with RNase A. Valyl-
cytidine was then isolated by DEAE-cellulose chromatography of the RNase A digest 
(Figure 8). DEAE-cellulose chromatography readily separates positively charged 
nucleoside esters from weakly absorbed free nucleosides, as well as strongly bound, 
negatively charged nucleotides. As can be seen from Figure 8, all the radioactive valine 
elutes with the first UV absorbing peak which contains the aminoacyl nucleoside. The 
second peak was identified as cytidine from its UV absorption spectrum. The UV 
spectrum of the first peak, after hydrolysis of the aminoacyl bond (see Methods), was 
compared to that of standard adenosme and cytidine under the same condition. It was 
found (Figure 8, inset) that the terminal nucleoside collected from the first DEAE-
cellulose peak has a UV spectrum very similar to that of cytidine but different from tiiat 
of adenosine. The molar ratio of valinercytidine in the isolated valyl-cytidine is 0.9, 
based on the known specific activity of ±e radioactive amino acid and the molar 
extinction coefficiency of cytidine at 270 nm at pH 7.0. The results demonstrate that 
valine is indeed esterified to the terminal cytidine of C76 tRNA^®" mutant. 
Figure 8. Isolation and characterization of valyl-cytidine. The tRNA^®' variant with a 
3'-CCC terminus was aminoacylated with pH]-valine and hydrolyzed with 
pancreatic RNase (see Methods). The digest was chromatographed on a DEAE-
cellulose column eluted with 0.02 M triethyl ammonium formate buffer, pH 4.6. 
Samples were collected, and the absorbance at 260 nm (closed circles, solid 
line) and radioactivity (open circles, dotted lines) were determined. (Inset) 
Fractions containing radioactivity were pooled, dried, and the aminoacylester 
bond hydrolyzed. The sample was then dissolved in 0.4 M Tris-HCl, pH 7.0 
buffer, and its UV absorption spectrum (open circles) compared with those of 
cytidine (closed circles) and adenosine (triangles). 
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Aminoacvlation of 3'-terminal variants of E. coli tRNA^ 
To study the 3' terminal sequence requirements for aminoacylation of other tRNAs, 
and to compare the tRNA^"'-VRS system, where VRS is a class I synthetase to the 
function of a class II enzyme, the aminoacylation of 3'-terminal variants of E. coli 
tRNA"^ was studied; alanyl-tRNA synthetase (AlaRS) is a class II synthetase. 
Even though all the tRNA^ variants can be fully ammoacylated at high ARS 
concentrations (5 /xM) (Table 3), their aminoacylation efficiency is reduced significantly 
compared to that of wild type tRNA"^. Figure 9 shows the time course of charging of 
wild type and 3'-terminal variants of tRNA^ with alanine. The initial rate of charging 
of mutant C76 tRNA'^ with alanine is about 15 % that of wild type tRNA"^; 
aminoacylation of the two other mutants, G76 and U76, is below the level of detection, 
indicating that they are very poor substrates for aminoacylation by AlaRS. The kinetic 
parameters of alanine aminoacylation for wild type and 3'-terminal variants of tRNA^ 
are compared in Table 3. 
Kinetic parameters for aminoacylation of the wild type tRNA'^' transcript obtained 
here are consistent with published results (134). The results show that the aminoacylation 
efficiency of all three 3' end mutant tRNA'^ transcripts is reduced, compared to wild 
type tRNA'^. Mutant C76 tRNA^ retains only about 13% aminoacylation efficiency 
(Vmax/KJ compared to wild type tRNA'^, due largely to a five-fold decrease in V^. 
Substimtion of A76 with G or U yields tRNA mutants that are almost inactive, resulting 
in a more than 200-fold decrease in aminoacylation efficiency (V^x/KJ compared to wild 
type tRNA'^'', although they are fully chargeable when high concentrations of AlaRS are 
Figure 9. The time course of aminoacylation with alanine of wild type tRNA"^'® (A76) 
(open circles) and variants with substitutions at their 3' termini: the U76 variant 
(open triangles), the C76 variant (closed circles), and the G76 variant (closed 
triangles). 
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used in the aminoacylation reaction (Table 3). It appears that the specific interactions 
between the 3' terminus of tRNA^ and ARS are somewhat different from those between 
tRNA^*^ and VRS (compare Table 2 and 3). VRS and ARS belong to two different 
classes of synthetase. However, no general conclusions can be drawn about the general 
interaction of class I and class II synthetases with the 3' end of their cognate tRNAs from 
a study of only these two systems (see Discussion). 
Table 3. Kinetic parameters for aminoacylation of wild type and 3' terminal tRNA'^ 
mutants 
tRNA'^ V ' max Relative 
Variants pmol/Ajfio (/iM) (/tmol/min/mg) V^/K^ V^nax/Ko. 
Wild type 1240 2.5 1.2 0.48 (1.0) 
C I S  1463 4.3 0.26 0.06 0.13 
G76 1482 - - 1x10-2 3.8x10-^ 
U76 1345 - - 1.2x10-2 4.6x10-2 
Function of 3'-Terminal Variants of E. coli tRNA^"* in in vitro Polypeptide Synthesis 
To further examine the function of tRNAs with substitutions for the universally 
conserved 3' terminal A, their activity in polypeptide synthesis was tested in an in vitro 
polypeptide synthesis system dependent on the addition of aminoacyl-tRNAs. 
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Aminoacylated tRNAs were used in these experiments in order to eliminate the 
effects of differences in aminoacylation efficiency of the tRNA variants. The random 
polynucleotide poly(U,G) (U:G = 3:1) functions as an efficient messenger RNA for 
polypeptide synthesis in these experiments, provided that E. coli tRNA""® and non­
radioactive phenylalanine are added (53). Several control experiments showed that 
omission of aminoacyl-tRNA, tRNA"", 70S ribosomes, or poly(U,G) result in total 
elimination of protein synthesis. Figure 10 shows the time course of polypeptide 
synthesis and its dependence on added poly(U,G). It is clear that the G76 mutant of 
tRNA^"* is an efficient donor of valine for polypeptide synthesis, there being little 
difference in its ability to incorporate valine into the polypeptides compared to wild type 
tRNA^"^. The other two mutants, C76 and U76, although they are much better 
substrates in the aminoacylation reaction compared to the G76 mutant, are very poor 
donors of valine for polypeptide synthesis. Control experiments, in which the treatment 
with hot 5 % TCA was eliminated, showed that the aminoacylated tRNAs are stable 
during the polypeptide synthesis reaction, effectively ruling out the possibility that the 
inability to incorporate valine into the polypeptide chain by the C76 and U76 tRNA^®' 
mutants is due to the instability of the aminoacyl linkage during the polypeptide synthesis 
reaction. These experiments show that the low activity of C76 and U76 tRNA^®" in 
protein synthesis is due to die failure of both C76 and U76 tRNA^"* variants to serve as 
efficient donors of valine in polypeptide synthesis. 
Figure 10. Poly(U,G)-directed (Val, Phe) copolypeptide synthesis. The time course 
of [^H]-labeled valine incorporation into polypeptide from aminoacylated wild 
type tRNA^®" (A76; open circles), the U76 mutant (closed circles), the C76 
variant (open triangles), and G76 mutant (closed triangles). 
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Fiinrtinn of tRNA^** Variants with Substitutions for the Cvtidines near the 3'-End 
Aminoacvlation of tRNA^'' variants at positions 74 and 75 
Aminoacylation kinetic studies of the tRNA^** variants with substitutions at positions 
74 nd 75 were also carried out. Table 4 lists the kinetic parameters for arainoacylation of 
these tRNA^*' variants with valine. 
Table 4. Kinetic parameters for aminoacylation of 74 and 75 mutant tRNA^"* variants 
tRNA^" K„ Relative 
Variant ( ixM)  (/imol/min/mg) 
Wild type 1.4 5.0 3.6 (1.0) 
A74 1.3 4.0 3.1 0.86 
G74 0.7 2.7 3.9 1.1 
U74 1.2 1.4 1.2 0.33 
A75 1.1 1.6 1.5 0.42 
G75 0.72 0.027 0.038 0.01 
U75 1.4 1.5 1.1 0.31 
U74U75 2.5 0.049 0.020 5.6x10'^ 
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The results demonstrate that the penultimate cytosine residues at the conserved 3'-
end of tRNA^'^are not essential for aminoacylation of the tRNA. Substitution of C74 by 
any other nucleotide yields tRNA mutants that function in aminoacylation with little 
decrease in aminoacylation efficiency (Vn„x/KJ. Replacement of C75 with A or U yields 
tRNAs that also retain significant aminoacylation activity. However, changing C75 to 
G75 decreases the aminoacylation efficiency 100 fold. The double mutant U74U75 is 
also relatively inactive in aminoacylation, with a relative V^/Kn, that is about 180-fold 
lower than that of wild type tRNA^^. It seems that the nucleotide at position 75 is more 
involved in the aminoacylation reaction than that at position 74. Similar to the mutations 
introduced at the 3' terminus of tRNA^*^, mutations at positions 74 and 75 affect 
more than K„. 
Activitv of tRNA^** variants at position 74 and 75 in polypeptide svnthesis 
In vitro poly(U,G)-directed polypeptide synthesis smdies with tRNA^®" variants 
having substitutions at position 74 and 75 were carried out using aminoacylated tRNAs. 
The time course of polypeptide synthesis (Figure 11, 12) shows that all of the tRNA^"^ 
variants at positions 74 and 75 are moderately active as donors of valine for polypeptide 
synthesis. All mutants at position 74 of tRNA"^"^ show almost equal polypeptide synthesis 
activity, 50% that of the wild type tRNA^" (Figure 11). The tRNA^"" variants at position 
75 show slightly different results from tRNA^"^ variants at position 74 (Figure 12). The 
U75 mutant retains higher polypeptide synthesis activity, about 60% that of wild type 
tRNA^*', than does the A75 mutant, 40% that of wild type tRNA^"". Control 
experiments show that in vitro polypeptide synthesis depends on added aminoacyl-tRNA, 
Figure 11. Poly(U,G)-directed (Val, Phe) copolypeptide synthesis. The time course 
of [^H]-labeled valine incorporation into polypeptide from aminoacylated 
wild type tRNA^"' (A76; closed circles), the U74 mutant (closed triangles, in an 
up direction), the C74 variant (closed squares), and G74 mutant (closed 
triangles, in a down direction). 
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Figure 12. Poly(U,G)-directed (Val, Phe) copolypeptide synthesis. The time course 
of [^H]-labeled valine incorporation into polypeptide from aminoacylated wild 
type tRNA^®' (C75; closed circles), the U75 mutant (closed squares), and the 
A75 variant (closed triangles), 
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poly(U,G) and 70S E. coli ribosomes. It is unclear at this point why U75 tRNA^^is a 
better substrate than A75 as a valine donor for polypeptide synthesis (see Discussion). 
The results here demonstrate that tRNA^*^ variants with substitutions at the conserved 3' 
cytidines of tRNA^*' can function in in vitro polypeptide synthesis. 
SpeciHc Recognition of E. cott tRNA^®* by Valyl-tRNA Synthetase (VRS) 
The correct aminoacylation of a tRNA by its cognate amino acid, catalyzed by an 
aminoacyl-tRNA synthetase, is very important for the fidelity and accuracy of protein 
synthesis. After an amino acid is esterified to the 3' end of a tRNA there is no other 
discriminatory mechanism present in later steps of protein synthesis. Therefore, the 
specific recognition of tRNAs by their cognate aminoacyl-tRNA synthetases, and the 
discrimination against recognition by non-cognate synthetases play important roles in 
determining the fidelity and efficiency of protein synthesis. Study of the specific 
recognition of E. coli tRNA^"^ by valyl-tRNA synthetase (VRS) and die search for 
identity elements of tRNA^^ was carried out in two different ways: first, the 
aminoacylation efficiency of valine tRNAs with mutations introduced directly into several 
regions of the molecule, including the anticodon loop and stem, the acceptor stem and the 
variable pocket of tRNA^** were determined. "F NMR spectroscopy of tRNA^®^ variants 
was used to probe tRNA structure and obtain information about the effects of mutations 
on the local or global structure of the tRNA molecule. Second, identity switch studies in 
which mutations are introduced into tRNA'^ and tRNA^*" at positions previously found to 
be important for recognition of tRNA^'^ by VRS were carried out. Aminoacylation 
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kinetic studies of the tRNA variants with valine were carried out to identify positive 
identity elements essential for VRS recognition and negative identity elements which 
prevent proper recognition by VRS. These experiments should help us understand the 
complexity of tRNA-synthetase mteractions inside the cell and how the high specificity of 
aminoacylation of E. coli tRNA^"^ is achieved. 
It was found previously in this laboratory and others that anticodon positions A35 
and C36 are very important identity elements of tRNA^®* (106, 120, 124). Mutations 
introduced into these two positions either totally abolish or greatly reduce the 
aminoacylation activity of the tRNA^®* variants. The following smdies focus on several 
other regions of tRNA^®", including the discriminator base (position 73), the acceptor 
stem, the T-loop and stem, the variable pocket, and the anticodon stem of tRNA^°', in 
order to determine other possible identity elements of tRNA^"^. 
ATninnapvlation Efficiency of E. coli tRNA^** Variants 
Discriminator base mutants of tRNA^*^ 
In order to study the importance of the discriminator base of tRNA^®' in recognition 
by VRS, aminoacylation kinetic studies of the tRNA^®' variants at position 73, C73, U73 
and G73, were performed (Table 5). 
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Table 5. Kinetic parameters for aminoacylation of wild type and tRNA^"^ variants at 
position 73 
tRNA^'^ 
Variants (MM) 
V ^ max 
Oxmol/min/mg) Vjoax/Km 
Relative 
Vnux/Kn, 
Wild type 
tRNA^"' 1.4 5.0 3.6 (1.0) 
C73 2.3 3.7 1.6 0.44 
U73 2.5 2.7 1.1 0.30 
G73 5.2 0.35 0.067 0.019 
The results demonstrate that substitution of the discriminator base A73 with either C 
or U does not reduce the aminoacylation activity of tRNA^*^ significantly. The 
aminoacylation efficiency (V^/KJ of the C73 and U73 is reduced only about 2-3 fold 
compared to that of wild type tRNA^®*. Replacement of A73 by G, however, reduces the 
activity of tRNA^** significantly, resulting in a 55 fold decrease in relative V^/Kn,, due 
mainly to a 9-fold decrease in V^. NMR study of the 5-fluorouracil-substituted G73 
tRNA^"'mutant (results not shown), showed that the overall conformation of the mutant 
tRNA is not perturbed by replacing A73 with G. This suggests that the relatively low 
aminoacylation efficiency of mutant G73 is not due to a structural perturbation of 
tRNA^"', but is due to either loss of proper contacts between the base at position 73 and 
VRS, or the creation of negative element(s) that results in a nonproductive interaction 
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between the tRNA^"* variant and VRS, or a combination of both possibilities. 
Acceptor stem mutants of tRNA^** 
Variants at position 4-69 
The U4-A69 base pair in the acceptor stem of tRNA^*^ is one of the sites predicted 
to be an identity element of tRNA^** by McClain et al. (122). In order to determme the 
importance of this base pair in the recognition of tRNA^®* by VRS, mutations were 
introduced to convert this base pair to all other base pairs, A4-U69, C4-G69, U4-G69, 
G4-U69, and G4-C69. The activity of these tRNA^'' variants were determined (Table 6). 
Table 6. Kinetic parameters for aminoacylation of tRNA^** mutants at position 4-69 
tRNA^-^ 
Variants (mM) 
V ^ max 
Oxmol/min/mg) Vjjjj3[/Kluj 
Relative 
Wild type 
tRNA^" 1.4 5.0 3.6 (1.0) 
A4-U69 1.6 4.9 3.1 0.86 
C4-G69' 1.4 4.0 2.9 0.80 
G4-C69'' 1.5 4.5 2.1 0.31 
U4-G69' 10.4 6.2 0.59 0.16 
Results were obtained by Vahid Feiz and Jack Liu in this laboratory, 
respectively. Shown here for comparison. 
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The results show that replacement of U4-A69 in wild type tRNA^®* by any 
Watson-Crick base pair yields tRNA variants active in aminoacylation. The relative 
V^/Km of the tRNA mutants containing the wobble base pairs U4-G69 and G4-U69, 
however, are reduced 8-10 fold, due largely to a 4-5 fold increase in Kn, (Table 6). 
Variants at other positions of the acceptor stem 
Several tRNA^®" variants with mutations in the acceptor stem were prepared (see 
Methods). Table 7 lists the kinetic parameters for aminoacylation of these tRNA^®* 
variants. The results show that substitution of G1-C72 with either G1-U72, A1-U72 or 
A1-C72 does not reduce the aminoacylation efficiency of the tRNA^"' variants 
significantly, indicating that either the presence of a wobble base pair, or the disruption 
of the first base pair in the acceptor stem does not lower the activity of tRNA^"" 
appreciably. Replacement of G2-C71 by either A2-U71, C2-G71, or the wobble base 
pair G2-U71 also does not reduce the aminoacylation activity of the tRNA"^®* mutants 
significantly. Replacement of G3-C70 with either C3-G70 or A3-U70 in the acceptor 
stem generates tRNA variants with relative values close to that of wild type 
tRNA^®'. However, substitution of G3-C70 with a G3-U70 wobble base pair yields a 
tRNA mutant with relative V^/K„ value of only 0.28. Table 7 also shows the kinetic 
parameters for ammoacylation of two other tRNA^"* mutants, G6-C67 and C7-G66 
(prepared by Vahid Feiz and included for comparison). 
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Table 7. Kinetic parameters for aminoacylation of acceptor stem mutants of tRNA^** 
tRNA^** 
Variants (/*M) 
V * max 
(jwmol/min/mg) V„^/K„ 
Relative 
Wild type 
tRNA^" 1.4 5.0 3.6 (1.0) 
A1-U72 1.6 5.2 3.3 0.92 
A1-C72 1.9 4.8 2.5 0.69 
G1-U72 1.5 5.7 3.8 1.1 
C2-G71 1.7 4.3 2.5 0.69 
U2-A71 1.6 5.0 3.1 0.86 
G2-U71 2.7 5.3 2.0 0.55 
A3;U70 1.5 4.6 3.1 0.86 
G3-U70' 1.8 1.9 1.1 0.31 
G6-C67' 2.3 5.7 2.5 0.69 
C7-G66' 1.6 3.8 2.4 0.66 
^ These results were obtained by Vahid Feiz in this laboratory. They are listed 
here for comparison. 
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The results show that these two mutants are active in ammoacyiation. Their 
aminoacylation efficiency (V^/KJ was reduced only a little compared to that of wild 
type tRNA^*". As can be seen from Table 6 and 7, mutations introduced into the acceptor 
stem of tRNA^"* have differential effects on the aminoacylation activity of the tRNA. 
The tRNA^*' mutants which contain normal Watson-Crick base pairs at position 4-69 are 
active in aminoacylation, whereas the mutant containing a G-U wobble base pair at the 4-
69 position has a relative V^/K„ value of only 0.16 (Table 6). 
NMR spectroscopy of the (FUra) tRNA"^ variants in the acceptor stem 
The results in Table 6 and 7 indicate that tRNA^®' variants with Watson-Crick base 
pair substitutions in the acceptor stem are quite active. However, introducing wobble 
base pairs into the 3-70 and particularly the 4-69 base pair positions in the acceptor stem 
affects the activity of the tRNA significantly. In order to investigate the effects of 
introducing wobble base pau* at positions 3-70 and 4-69 of tRNA^^'on the conformation 
of tRNA^"*, NMR studies of these tRNA^®^ variants, labeled by incorporation of 5-
fluorouracil, were carried out. NMR spectra are very sensitive to changes in tRNA 
structure (see Introduction). 
Replacing a G-C base pair with a G-FU base pair in the acceptor stem of 
(Fura)tRNA^*' results in the appearance of an extra peak in the downfield region of the 
^'F NMR spectrum of (Fura)tRNA^'', between 7 and 8 ppm, (Figure 13), as expected for 
resonances from 5-FUra residues involved in wobble base pairs (50). Introducing G-FU 
base pairs at G2-C71 or G3-C70 results in a downfield shift of the resonance from FU4 
(Figure 13). Peak FU4 shifts 0.39 ppm downfield, to partially overlap with FU67, in the 
Figure 13. ''F NMR spectra of wild type and (FUra)tRNA^®' variants with a G-U 
base pair present at different positions in the acceptor stem. All spectra were 
recorded at SCC. Chemical shifts are reported downfield from free 5-
fluorouracil (5-FUra = 0 ppm at 22°C). A. wild type (FUra)tRNA^'"; B. Gl-
FU72 variant; C. G2-FU71 variant; D. G3-FU70 variant; E. FU4-G69 variant 
Peak numbers correspond to 5-FUra residues located at different positions in 
the tRNA. 
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spectrum of mutant G2-U70, and shifts 1.92 ppm downfield, overlapping with FU7, in 
the spectrum of mutant G3-U70. Replacing the FU4-A69 base pair with FU4-G69 results 
in a 4.43 ppm downfield shift of resonance FU4. There is a progressive downfield shift 
of resonance FU4 with the introduction of base pairs near the U4-A69 base pair position 
of tRNA"^*^. The chemical shift position of FU4 is changed only slightly by introduction 
of a G1-FU72 wobble base pair (Figure 13). Other resonances in the spectra of 
(FUra)tRNA^^ variants, U70, U71, and U72 do not shift compared to the spectrum of 
wild type (Fura)tRNA^*' (Figure 13), suggesting that the mutations in the acceptor stem 
have no effect on the global three dimensional structure of tRNA molecule, 
"F NMR spectra of tRNA'^*' variants containing A-U base pairs in place of G-C 
base pairs at positions 2-71 or 3-70 were also recorded (Figure 14). The spectra are 
similar to that of wild type (FUra)tRNA^'^ except for the extra peaks in the upfield 
region of the spectra, which correspond to die additional FU residues incorporated into 
the tRNAs. Unlike the tRNA^®* mutants containing G-U base pairs at positions 3-70 and 
4-69, ^'F NMR spectra of tRNA^"* mutants containing A-U base pairs at these positions 
show only small shifts in the position of FU4 (Table 8). 
Determination of the aminoacylation kinetics of these tRNA^*^ variants (Table 6 and 
7) shows that tRNA^"^ variants with Watson-Crick base pairs at positions 4-69 and 3-70 
are good substrates for VRS, suggesting that the functional groups on the U4-A69 and 
G3-C70 are not directly recognized by the enzyme (see Discussion). 
Figure 14. "F NMR spectra of wild type and (FUra)tRNA^®' variants. Spectra were 
recorded at 30°C. Chemical shifts are reported downfield from 5-fluorouracil 
(5-FUra = 0 ppm at 22°c). A. wild type (FUra)tRNA^®'; B. FU2-A71 variant; 
C. A3-FU70 varinat. 
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Table 8. chemical shifts of resonances corresponding to 5-fluorouracil residues in the 
acceptor stem of (FUra)tRNA^*' variants. 
Chemical shift 3ppm from 
(ppm) wild type' 
tRNA"^** Relative 
Variants FU4 FU67 FU7 FU4 FU67FU7V^/K„ 
Wild type 2.06 2.70 3.98 0 0 0 (1) 
G1-FU72 2.06 2.66 3.97 0 -0.04 -0.01 1.06 
G2-FU71 2.45 2.57 3.98 0.39 -0.13 0 0.56 
G3-FU70 3.98 2.61 3.98 1.92 -0.09 0 0.31 
FU4-G69 6.49 2.68 3.82 4.43 -0.02 -0.16 0.17 
G6-FU67 2.01 7.54 3.10 -0.05 4.84 -0.88 0.86 
FU7-G66 2.06 2.93 6.64 0 0.23 2.66 ND 
A3-FU70 2.35 2.66 4.04 0.29 -0.04 0.06 0.86 
FU2-A71 1.96 2.66 4.01 -0.10 -0.04 0.03 0.86 
Sppm = ppm (mutant tRNA) - ppm (wild type tRNA) 
ND; Not determined. 
Anticodon stem variants of tRNA^** 
To study the recognition of tRNA^"' by VRS in the anticodon stem, 
oligonucleotide-directed mutagenesis was carried out to introduce mutations in the base 
pair 29-41. Replacing the wild type U29-A41 base pair with a C-G base pair lowers the 
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Table 9. Aminoacylation kinetic parameters for tRNA^"^ variants in the anticodon stem. 
tRNA^-^ 
Variants (MM) 
V ^ max 
(/tmol/min/mg) Vmax/Km 
Relative 
Wild type 
tRNA^-^ 
(22°C) 1.3 2.1 1.6 (1.0) 
i31°C) 1.4 5.0 3.6 (1.0) 
(47°C) 2.3 7.7 3.3 (1.0) 
C29:G41 
(22°C) 6.3 0.51 0.081 5.0x10-2 
(3700 14.6 2.2 0.15 4.2x10-2 
(47°C) 18.2 3.3 0.18 5.5x10-2 
A29:U41 2.4 5.1 2.1 0.58 
U30:A40 2.0 5.6 2.8 0.77 
aminoacylation efficiency (V^/KJ (assayed at 37°C) 47 fold, due largely to a 10 fold 
increase in K„ (Table 9). "F NMR spectrum of this mutant, recorded at 22°C, shows 
some shifts of resonances corresponding to 5-fluorouracil residues in the anticodon loop, 
compared to the spectrum of wild type (FUra)tRNA^''' (139), suggesting that changing an 
U-A base pair to a C-G at position 29-41 affects the conformation of the anticodon loop 
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(see Discussion). However, the "F NMR spectrum of the 29C-41G mutant, recorded at 
47°C, failed to show these spectral differences; at the higher temperature the spectrum 
closely resembles that of wild type tRNA^*' (139). Aminoacylation kinetic study showed 
that the relative aminoacylation efficiency (V^/KJ of this tRNA variant remains low 
even at 47°C (Table 9). Change of the base pair U29-A41 to U29-G41 (carried out by 
Vahid Feiz) generates a tRNA mutant with a relative V^/Km value of 0.22. To further 
study and understand the possible role of this base pair in tRNA^*^ function, another 
mutant which contains an A-U base pair, in place of the U-A base pair, at position, 29-41 
in wild type tRNA^*", was created. Kinetic studies showed that the relative 
aminoacylation efficiency (V^/KJ of this mutant is 0.54, suggesting that it is quite 
active in aminoacylation. Clearly, die aminoacylation activity of mutant A29-U41 is very 
different from that of mutant C29-G41 (Table 9). The results with mutant A29-U41 do 
not necessarily mean that the base pair U29-A41 is not a recognition site of tRNA^"^ (see 
Discussion). Further experiments are probably required for clarify this matter. Study of 
base pair position 30-40 by Vahid Feiz indicated that this base pair probably is not a 
recognition site of tRNA^"' and this conclusion was supported by the study of the 
recognition of tRNA'^ variants by VRS, described below. 
T-loop and stem. D-loop and the variable loop variants of tRNA^** 
Aminoacylation oftRNA^"' variants 
The effect on aminoacylation activity of nucleotide substitutions in the T-stem and 
loop, the D-stem and loop, and the variable pocket region, which is formed by the 
interaction between the T-loop and stem and D-loop and stem of tRNA^®' and includes 
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position 17, 20 and 59 of tRNA^*', were also investigated (Table 10). 
The results show that mutations introduced into the T-stem and loop, as well as in 
the variable loop of tRNA^'' do not reduce the aminoacylation activity of the tRNAs 
significantly. However, mutations introduced at position 20 lower aminoacylation 
efficiency (V^/KJ 3-4 fold compared to that of wild type tRNA^"*, suggesting that the 
nucleotide at position 20 of tRNA^'' may be a recognition site of tRNA^'^. 
NMR spectroscopy of the (FUra)tKNA!'''^ variant at position 20 
As mentioned above, replacement of G20 in the variable pocket of tRNA^®* by any 
other nucleotide yields tRNA^®" mutants that retain only 20%- 30% aminoacylation 
activity compared to wild type tRNA^"* (Table 10). The effect (s) of mutations at 
position 20 on the conformation of tRNA^"^ were studied by examing the NMR 
spectra of mutant C20 at different temperatures, 22''C and 47°C. The *'F NMR spectra 
of wild type and (FUra)tRNA^'''mutant C20 were compared at 22°C (Figure 15) and at 
47°C (Figure 16), respectively. The overall spectrum of (FUra)tRNA^*' mutant C20, 
recorded at 22°C, is similar to that of wild type (FUra)tRNA^'' except that in the ^'F 
NMR spectrum of mutant C20, resonance FU59 shifts up field, its intensity decreases, 
resulting hi a broadening of the peak (Figure 15). It is difficulty to determine exactly 
where peak FU59 shifts. In addition, resonance FU54 shifts 0.15 ppm up field. It 
appears that the peaks that correspond to residues FU33/FU47 and that which 
corresponds to residue FU17 shift 0.1 ppm down field, whereas the chemical shift 
position of resonance FU34 remains unchanged (Figure 15). The " F NMR spectrum of 
mutant C20, recorded at 47°C, is similar to that of the mutant recorded at 22''C (Figure 
Figure 15. "F NMR spectra of wild type and (FUra)tRNA^^' variant C20. Spectra 
were recorded at 22°C. Chemical shifts are reported downfield from 5-
flouorouracil (5-FUra = 0 ppm at 22°C). A. (FUra)tRNA^^' variant C20; B. 
wild type (FUra)tRNA^®' 
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Figure 16. "F NMR spectra of wild type and (FUra)tRNA^''' variant C20. Spectra 
were recorded at 47°C. Chemical shifts are reported downfield from 5-
flouorouracil (5-FUra = 0 ppm at 22°c). A. (FUra)tRNA^®' variant C20; B. 
wild type (FUra)tRNA^®'. 
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Table 10. Kinetic parameters for aminoacylation of tRNA^"^ variants in T-loop, stem and 
D-loop and stem, as well as the variable loop of tRNA^*' 
tRNA^" K„ Relative 
Variants (jjlM) Otmol/min/mg) V^/K„ V^/K„ 
Wild type 
tRNA^" 1.4 5.0 3.6 (1.0) 
T-stem and loop 
C59 1.2 4.0 3.3 0.92 
C64 1.3 5.9 4.5 1.3 
D-stem and loop 
C17 1.2 4.9 4.1 1.1 
A20 4.7 6.4 1.4 0.38 
C20 7.1 5.8 0.81 0.22 
U20 4.9 4.3 0.88 0.24 
Variable loop 
C47 1.1 4.6 4.2 1.2 
Tertiary interactions 
A44 3.5 4.4 1.3 0.35 
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16). The resonance corresponding to FU59 shifts 0.34 ppm upfield. It appears that at 
47°C, resonances that correspond to FU34 and FU17 do not shift, whereas resonance 
corresponding to FU47 shift down field to overlap with resonance FUSS, resulting in an 
increase in the peak intensity (Figure 16). FU59 is located in the variable pocket of 
tRNA^*", whereas FU47 is located in the variable loop. In yeast tRNA^**®, the variable 
loop region contains the G44, G45, G46, and C48 that are involved in the tertiary 
interaction of the tRNA molecule. These results suggest that introducing C at position 20 
alters the conformation of the variable pocket of tRNA^®*. In addition, the tertiary 
folding of the variable loop may also be affected by the mutation. 
Identity Switch Studies 
The fidelity of protein synthesis not only depends on the efficient and productive 
interaction of a given tRNA molecule with its cognate aminoacyl-tRNA synthetase inside 
the cell, but it also depends on how noncognate tRNA molecules and synthetases 
discriminate against each other, so that mischarging of a tRNA with the wrong amino 
acid does not occur. To fturther investigate the structural requu-ements for the 
recognition of E. coli tRNA^^ by VRS, and to uncover possible negative determinants or 
structural features present in other tRNAs which prevent productive interactions between 
noncognate tRNAs and VRS, identity switch studies were carried out to insert the known 
recognition elements of tRNA"^"* into E. coli tRNA^ and tRNA^*"®. 
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Switching the identity from E. coli tRNA^ to tRNA^*' 
Figure 17 shows the sequence comparison between E. coli tRNA'^*' and tRNA'"^. E. 
coli tRNA^ differs from tRNA^'' by only 19 nucleotides, most of which are located in 
the acceptor stem, anticodon stem and loop regions of both tRNAs (Figure 17). Clearly 
a mechanism is required for the two synthetases to discriminate between the tRNAs, 
while efficiently recognizing their own cognate tRNA by virtue of some unique sequences 
or structural features in the tRNA molecules. The anticodon base A35 is an important 
identity element of tRNA^'' and is absent in tRNA'^. In addition to the major difference 
in the anticodon loop, some additional base(s) might be present in tRNA'^ to prevent 
VRS recognition. The G3-U70 base pair in the acceptor stem of tRNA^ is an important 
identity element of tRNA'^ (see Introduction); tRNA^^ mutant G3-U70 showed 
relatively low aminoacylation activity (Table 11). To further examine the identity 
elements of tRNA^®* and to identify possible negative determinants which mhibit VRS 
recognition, several mutations were introduced into tRNA'^ step by step to determine 
which nucleotides are essential to switch its identity to that of a valine-accepting tRNA 
(Table 11) (Figure 17). Substitution of anticodon G35 with A35 in tRNA^ markedly 
increases the valine charging efficiency of tRNA"^. However, the relative of 
this tRNA is still about 6-fold lower than that of wild type tRNA^"', possibly due to the 
presence of a wobble base pair at position 3-70 of tRNA'^, since it was shown that the 
tRNA^** variant containing the same base pair G3-U70 is relatively inactive in 
aminoacylation (Table 11). 
Figure 17. Comparison of the nucleotide sequences of E. coli tRNA^®" (UAC anticodon) and tRNA^'® (UGC anticodon). 
The shaded regions indicate sequence differences between the two tRNAs. Site-directed mutagenesis were 
carried out to change the anticodon base 035 of tRNA'^'® to A35, and base pair G3-U70 to G3-C70 and A3-
U70, respectively. 
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Table 11. Aminoacylation kinetics of E. coli tRNA^ variants with valine 
tRNA Species 
(MM) 
V * max 
(/tmol/min/mg) Vn^/K„ 
Relative 
V^/K„ 
WUd type 
tRNA^^ 1.3 5.1 3.9 (1.0) 
tRNA^ (UAC) G3:U70 1.1 0.31 0.28 7.2x10"-
tRNA'^ (UAC)G3:C70 0.8 2.4 3.0 0.77 
tRNA-^ (UAC)A3:U70 0.73 2.8 3.8 0.97 
tRNA^(UGC) No Detectable Aminoacylation 
tRNA^ (UGC)G3:C70 46.7 0.27 0.006 1.5x10"' 
tRNA^ (UGC)A3:U70 — — 0.0024 6.1x10^ 
Although the change of U70 to C70 alone increases the valine charging efficiency of 
tRNA'^, its relative V^/K„ is still quite low (Table 11). Changing both G35 to A35, 
and U70 to C70, however, yields a tRNA molecule very active in accepting valine, with 
a relative V^/K^ of 0.94 compared to that of wild type tRNA^"^ (Table 11). To 
investigate whether the G3-C70 base pair is really a recognition site of tRNA^®^, or 
whether the G3-U70 in tRNA^ acts as a negative determinant for valine charging, a G 
to A change was made at position 3 of tRNA"^ to yield a tRNA with A3-U70 base pair 
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(Figure 17). The aminoacylation activity of this mutant is almost as good as that of wild 
type tRNA^"" (Table 11), indicating that the G3-C70 base pair is not specifically 
recognized by VRS. The G3-U70 base pair in tRNA^ probably acts as a negative 
element to prevent proper recognition of this tRNA'"" by VRS, presumably by altering the 
conformation of the acceptor stem of the tRNA (see Discussion). The sequence in the 
lower region of the acceptor stem of the valine-accepting tRNA^ variants is quite 
different from that of tRNA^" (Figure 17), and in particular it lacks the U4-A69 base 
pair. These suggest that the U4-A69 base pair is not required for efficient recognition of 
the mutant tRNA^ by VRS. 
The aminoacylation studies of tRNA^ variants with valine supported the conclusion 
from the study of tRNA^"* mutants that the anticodon base A35 is very important for the 
aminoacylation activity of tRNA^®'. Furthermore, the study also suggested that the U4-
A69 base pair does not contain functional groups that are directly recognized by VRS, 
and the G-U base pair at position 3-70 of tRNA'^ probably acts as a negative determinant 
to prevent proper recognition of tRNA^ by VRS. 
The C30-G40 base pair in the anticodon stem of tRNA^*' was predicted to be a 
recognition site of the tRNA by McClain et al. (see Introduction). However, study of the 
recognition of tRNA^® mutant by VRS shows that tRNA'^ mutants having the valine 
anticodon (UAC) and substitutions for the G3-U70 wobble base pair are actively 
aminoacylated with valine, even though they have a G3-C40 base pair in place of C30-
G40 (Table 11). This suggests that base pair C30-G40 is not essential for the recognition 
of tRNA''"'. 
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Switching the identity from E. coli tRNA"" to tRNA^** 
As can be seen from Figm-e 17, the sequence of tRNA^ differs from tRNA^"^ in 
only 19 positions; some of the nucleotides that are common to both tRNA species may 
play a role in the recognition of wild type tRNA^*" and tRNA"^ variants by VRS. In 
addition, different noncognate E. coli tRNAs may use different strategies, to prevent 
recognition by VRS, by virtue of the negative determinants present in these noncognate 
tRNAs. For this reason, E. coli tRNA"" was chosen for ftirther study of the recognition 
of tRNA by VRS. Figure 18 shows a sequence comparison between E. coli tRNA^^'and 
tRNA'"". tRNA""® differs significantly from tRNA^'^ in several regions, including most of 
the acceptor stem, the entire anticodon stem, part of the anticodon loop and part of the T-
stem. Wild type tRNA®'*'® is a very poor substrate for VRS; its level of aminoacylation 
with valine is not detectable under normal experimental conditions (Table 12). Clearly a 
mechanism is present that prevents the productive interaction of tRNA®''" with VRS. 
Sequence comparison of tRNA^"^ and tRNA'"'® (Figure 18) shows that one of the major 
identity elements of tRNA^"*, the anticodon C36, is absent from tRNA^®, being replaced 
by A36. Another possible recognition site of tRNA^"^, G20 in the variable pocket of 
tRNA^®", is replaced by U20 in tRNA^®. In addition, the whole anticodon stem of 
tRNA"'® is different from that of tRNA'^*', and it is possible that die anticodon stem of 
tRNA""® may contain negative determinants that prevent proper recognition of this tRNA 
by VRS (see Discussion). A series of oligonucleotide-directed mutagenesis experiments 
were carried out to switch the identity of tRNA^*"®, step by step, to that of tRNA^®" by 
introducing mutations into position 36 in the anticodon loop, position 20 in the variable 
Figure 18. Comparison of the nucleotide sequences of E. coli tRNA^®' (UAC anticodon) and tRNA""^ (GAA anticodon). 
Shaded regions indicate sequence differences between the two tRNAs. 
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pocket, and part of the anticodon stem. Figure 19 shows the sequence of the tRNA"" 
variant resulting from these mutations. The kinetic parameters for aminoacylation of 
these tRNA""® variants with valine are presented in Table 12. The results show that 
replacement of A36 by C36 in the anticodon loop significantly increases the valine 
Table 12. Aminoacylation kinetic parameters of tRNA™® variants with valine 
tRNA 
Species 
Relative 
OtM) (/tmol/min/mg) V^/K„ V^/K„, 
Wild type 
tRNA^'' 1.4 5.0 3.6 
Wild type tRNA"" No Detectable Aminoacvlation 
Wild type tRNA"*' 
^tRNA"'®G20 No Detectable Aminoacvlation 
(1.0) 
WUd type tRNA"« 
->tRNA^'C36 20.3 
tRNA"'®C36 
^tRNA^'''C36G20 
= 9.0 
*p -» *p + 
C27C28U29'' 
G43G42A41 3.5 
0.78 
1.29 
4.9 
0.038 
0.12 
1.40 
0.01 
0.037 
0.40 
* *P stands for tRNA""® variant containing nucleotides C36 and G20. 
'' additional mutations were introduced into base pair positions 27-43, 28-42, 29-41. 
Figure 19. Conversion of wild type E. coli tRNA'"'"® (anticodon GAA) into an active valine-charging tRNA'"''® variant that 
contains anticodon nucleotide C36, G20 in the variable pocket, and base pairs C27-G43, C28-G42, and U29-
A41 in the anticodon stem. 
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acceptance of tRNA"" (GAC). However, this tRNA^ variant has a relative V^/K„ of 
only 0.01 (Table 12) compared to that of wild type tRNA^"*, indicating that even with the 
anticodon base changes and the presence of A73, the tRNA"*® (GAC) mutant is not a 
good substrate for VRS. To test whether the nucleotide at position 20 of tRNA^*" may be 
responsible for the low activity of this variant, U20 was replaced by G20 to yield the 
tRNA^® variant tRNA''''"'(GAC)G20. The relative aminoacylation efficiency (V^/KJ of 
this tRNA with valine is increased 3.7 fold compared to fliat of the tRNA""(GAC) 
mutant. The aminoacylation activity of this tRNA, however, is still low, only 3.7% that 
of the wild type tRNA^**, indicating that additional changes need to be made to increase 
the activity of this tRNA. Replacement of three base pairs, 27-43 to 29-41, in the upper 
part of the acceptor stem of the tRNA^' variant, tRNA"'®(GAC)G20, by the three base 
pairs found in the same positions in tRNA^"', yields a tRNA^"® variant, 
tRNA""'(GAC)G20C27C28U29A41G42G43, with a significantly increased aminoacylation 
efficiency (V^/KJ value, 40% that of wild type tRNA^'^, although the sequence of this 
tRNA®"*" variant differs by 24 nucleotides from that of tRNA^®* (Figure 19). 
The results suggest that either the anticodon stem of tRNA^' contains some negative 
determinants which prevents proper recognition of the tRNA by VRS, or some positive 
recognition elements, which are present in the anticodon stem of tRNA^^', are missing in 
the anticodon stem region of tRNA""®, or both (see Discussion). These results clearly 
demonstrate that mutant tRNA"® containing A35, C36, the discriminator base A73, G20 
in the variable pocket, and C27-G43, C28-G42 and U29-A41 is a good substrate for 
aminoacylation with valine. 
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DISCUSSION 
E. coli tRNA Mutants with Modifications in the Uniyersally Conserved 3'-CCA End 
Function of 3' End tRNA Mutants in Aminnarvlatinn 
The role of the 3' CCA end of E. coli tRNA^*^ in aminoacylation was investigated, 
by preparing 3' end tRNA^®* variants, to study the effect of mutations on the activity of 
tRNA^"* in vitro. The universally conserved 3'-CCA end of tRNA suggests that it is 
essential for the aminoacylation process. Study of the 3'-end variants of E. coli tRNA^*", 
however, indicates that functionally active tRNA^'' mutants with modifications at the 
universally conserved 3'-CCA end can be obtained. The results show that the 
aminoacylation efficiency (Vnax/KJ of the 3' end mutant G76 is about 160 fold lower 
than that of wild type tRNA^®*, suggesting that it is a poor substrate for VRS, although it 
can be fully charged with valine when a high VRS concentration is used. Surprisingly, 
the other two mutants, C76 and U76, are active in aminoacylation, having an 
aminoacylation efficiency (V^/KJ that is 40-50% that of wild type tRNA^"* (Table 2). 
End group analysis reveals the absence of adenosine at the 3' end of the tRNA^'* mutants 
and identifies the nucleotide expected from the sequence of the DNA template as the 
predominant 3' terminal residue (Figure 6); valyl-cytidine was isolated from the 
aminoacylated C76 mutant (Figure 8). These results have just been published (140). 
Recently, Tamura et al. reached the same conclusion in studying the aminoacylation 
activity of 3' end tRNA^*' mutants (141). Evidently, the 3' terminal adenosine is not an 
absolute requirement for aminoacylation of tRNA^®'. In contrast, recent study (142) 
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shows that in the case of E. coli tRNA"'®, changing A76 to C76 results in a tRNA"'® 
mutant that is essentially inactive in aminoacylation (142). The 2' or 3' hydroxyl group 
of the 3' end nucleotide (#76) of tRNA is a site of amino acid attachment. The 2' or 3' 
hydroxyl group of tiie 3' terminal nucleotide of tRNA is presumably positioned properly 
by interaction with amino acid(s) at the active site of the synthetase, through hydrogen-
bonding that involves the hydrogen bond donor (d) and acceptor (a) groups of the 3' 
terminal base. This suggests that as long as a proper hydrogen bonding network is 
maintained between the terminal nucleotide of tRNA and the active site of the 
synthetase, the interaction between the 3' end of tRNA and synthetase is maintained and 
the aminoacylation process is not hampered significandy. When the pattern of hydrogen-
bonding donor (d) and acceptor (a) groups of adenosine is compared to those of cytidine, 
uridine, and guanosine, it is found that cytidine and uridine, but not guanosine, resemble 
adenosine m their hydrogen-bond donor and acceptor pattern (Figure 20). This 
commonality may explain why the two bases, cytosine and uracil, but not guanosine, can 
functionally substitute for the 3' terminal adenosine of tRNA^"*. It also suggests that the 
exocyclic amino group (N6) and the N1 on the pyrimidine ring of the 3' terminal 
adenosine are involved in hydrogen-bonding at the catalytic site of VRS. This model 
suggests that it is the ability of the 3' terminal nucleotide to form proper hydrogen-bonds 
with amino acid(s) at the active site of VRS that is important for die function of the 3' 
terminal nucleotide in aminoacylation of tRNA^®^. This kind of hydrogen-bonding pattern 
between the 3' end of tRNA and its cognate synthetase has been observed in the crystal 
structure of yeast aspartyl-tRNA synthetase (AspRS) complexed with tRNA'^''' (143). In 
Figure 20. Structures of purine and pyrimidine nucleotides showing the hydrogen 
bond acceptor (a) and donor (d) sites used for base-pairing. The shaded arrows 
indicate the a d hydrogen bond donor-acceptor pattern common to A, C, U, but 
absent in G. 
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this tRNA-synthetase complex, the 7-OH group of a serine residue in the active site of 
AspRS forms hydrogen bonds with the exocyclic amino group (N6) and N1 of the 3' 
terminal adenosine of tRNA^^. 
To study the structural requirements of die 3' end of other tRNAs in aminoacylation 
and to compare them with tRNA^'^-VRS system, E. coli tRNA'^ was chosen and the 
effect of 3' terminal mutations on the aminoacylation activity of tRNA'^ was studied. 
This is especially interesting since alanyl-tRNA synthetase (AlaRS) is a class II 
synthetase, whereas VRS belongs to class I. The results show that the ammoacylation 
activities of all 3' end tRNA^ variants are reduced compared to that of wild type 
tRNA'^. Whereas mutant C76 of tRNA^, like the same mutant of tRNA'^'^, retains the 
highest aminoacylation activity among all the tRNA^*® variants, it has only 13% the 
activity of wild type tRNA^ (Table 3). This is almost four times lower dian 
the relative activity of the same mutant of tRNA^"^, Unlike mutant U76 of tRNA'^'^ which 
is active in valylation, mutants U76 and G76 of tRNA"^ are inactive in alanine charging, 
although the two tRNA^ mutants can be fully charged with alanine when a high 
concentration (> l/*g/jul) of AlaRS is used for aminoacylation. It is possible that the 
exocyclic amino group and/or the N1 on the pyrimidine ring of the 3' terminal nucleotide 
of tRNA^ is recognized by AlaRS, since tRNA'^ mutant C76 retains appreciable activity 
(13% that of wild type tRNA^) in alanine charging. It is also possible that more 
structural features of the 3' terminal nucleotide of tRNA^ are required for optunal 
interaction between tRNA'^ and AlaRS, since mutant U76 of the tRNA, unlike the same 
mutant of tRNA^^', is essentially inactive. Therefore, it appears that VRS and AlaRS 
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have somewhat different structural requirements in recognizing the 3' terminal nucleotide 
of their cognate tRNAs during aminoacylation, and perhaps the functional groups on the 
3' terminal A of tRNA^ are more strictly required in the tRNA^-AlaRS interaction. It 
is difficult to draw any general conclusions regarding the general mode of tRNA 
recognition by class I and class II synthetase based only on the results of studies with the 
tRNA^"^ and tRNA'^ systems. It will be interesting to see whether some class I 
synthetases, grouped in die same subclass as VRS, behave in the same way in 
recognizing the 3' terminal nucleotide of their cognate tRNAs. It will also be interesting 
to find out whether some class II synthetases, grouped in the same subclass as AlaRS, 
behave similarly to AlaRS in interacting with the 3' terminal A of their cognate tRNAs. 
Function of 3' End tRNA^** Mutants in Polypeptide Synthesis 
A number of previous studies indicated that the 3' end of tRNA participates in many 
steps of protein synthesis (see Introduction). The universal conservation of die 3'-CCA 
end suggests that it is essential for the function of tRNA in protein synthesis. Results of 
the studies presented here, however, suggest that tRNA^®* variants with modifications at 
the universally conserved 3'-CCA end can function in the later steps of protein synthesis. 
Studies of the activity of 3' terminal tRNA^®' variants in polypeptide synthesis used 
aminoacylated tRNA^"' in order to eliminate effects of differences in aminoacylation 
efficiency for different tRNA^"' variants. The results show that wild type tRNA^®' is an 
active valine donor in polypeptide synthesis. The 3' end tRNA^"' mutants C76 and U76 
that are highly active in aminoacylation, are poor substrates as valine donors for the later 
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steps of protein synthesis (Figiire 10). However, the G76 mutant, although it is a much 
poorer substrate in the aminoacylation step, compared to mutants C76 and U76, is a good 
substrate in later steps of polypeptide synthesis. The time course of polypeptide synthesis 
show that there is little difference in the efficiency of polypeptide synthesis between wild 
type tRNA^'^and the G76 mutant (Figure 10). This is the first example showing the 
function of 3' end variants of a tRNA in polypeptide synthesis. 
Early studies showed that different modifications at the 3' terminus have different 
effects on ternary complex formation (1). Whereas many modifications of die 3' cytidine 
residues of tRNA^' do not affect the ability of aminoacyl-tRNA to participate in ternary 
complex formation with EF-Tu and GTP, replacing the 3' cytidines with uridines inhibits 
die ability of phenylalanyl-tRNA""*" to participate in ternary complex formation (144). 
Studies also showed that modifications at the 3' terminus of tRNA""® have a more 
pronounced effect than those occurring at positions 74 and 75 (145). 
The role of the 3' terminus of tRNA in ribosomal A, P, and E-site binding has been 
studied extensively using different approaches (1, 146). Chemical footprinting studies 
show that the protection of bases in 23S rRNA by tRNA is progressively abolished by 
deletion of the aminoacyl group, 3' adenylate, or 3' cytidyladenylate from the conserved 
3' CCA terminus, suggesting that the interactions between the P-site bound tRNA and the 
23S rRNA involve mainly the conserved 3' CCA end of tRNA (41). The importance of 
the CCA end of tRNA in E-site binding was demonstrated by Wintermeyer and co­
workers who showed that tRNA binding to the E-site is greatly reduced by changes at the 
3' end (42). An effect of alteration at the CCA end on die rate of translocation and on 
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EF-G function has been observed (44). Based on these results, it was hypothesized that a 
base pairing interaction between the 3' terminal A of tRNA"" and a complementary 
sequence, containing a GGU, within the central loop of domain V of 23S rRNA may play 
an important role in tRNA binding to the ribosomal E site and in the translocation step 
(44), Our results showing the activity of tRNA^"* variants in polypeptide synthesis are 
consistent with this proposal. tRNA^"" mutants C76 and U76 are unable to form base 
pairs with the U base on 23S rRNA, therefore, they are inactive in protein synthesis. In 
contrast, mutant G76 retains significant activity in polypeptide synthesis, presumably 
because it can form a wobble G-U base pair with 23S rRNA. 
It was reported that mutant suj genes, coding for tRNA'^^suj'^ with nucleotide 
substitutions for the 3' adenosine, can efficiently produce functional suppressor tRNAs in 
E. coli (147). Function of the suppressor tRNAs requires that the cell retains tRNA 
nucleotidyltransferase and exoribonuclease activities (147). This indicates that removal of 
the incorrect 3' terminal residues and resynthesis of the normal -CCA terminus are 
occurring in this situation. It was also found by these authors, however, that a low level 
of tRNA suppressor activity exists even in cells that lack the tRNA nucleotidyltransferase 
activity. The authors pointed out that E. coli may contain an unknown enzyme 
responsible for repairing the 3' end of tRNA in the absence of tRNA 
nucleotidyltransferase activity, and argued against the possibility that mutant tRNA'^^^'suj'^ 
with substitutions for the 3' terminal A are capable of accepting tyrosine and functioning 
as suppressors in protein synthesis. The specific interaction between the 3' terminal A of 
tRNA^^ and tyrosyl-tRNA synthetase (TyrRS) may be different from that between 
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tRNA^'^and VRS, and TyrRS may have different functional group requirements for 
recognition of the 3' terminal A of tRNA^. . 
Fiinctinn of the 3' r.vtiHinp-s in the Aminoacylation of tRNA^*  ^
Our results show that functionally active tRNA"^'' variants with substitutions for the 
conserved cytidines at positions 74 and 75 can also be obtained. Whereas mutant U74 
retains one third the aminoacylation efficiency of wild type tRNA^®', the other 
two mutants, A74 and G74, are fully active in aminoacylation. Mutations introduced into 
position 75 have greater negative effects on the activity of tRNA^"* than those introduced 
into position 74. Mutant G75 retains only 1 % the aminoacylation activity (V^/KJ of 
wild type tRNA^®'. Evidently, the cytidine residue at position 75 is more involved in 
tRNA^'^-VRS interaction than the one at position 74. Our results on the function of 
tRNA^"* variants at position 74 are consistent with the findings of O'Connor et al. that E. 
coli tRNA^®" mutants with 3'-GCA and 3'-ACA sequences can function in vivo (45). 
Our results show that introducing a U at position 74 or 75 does not affect the 
aminoacylation activity of tRNA^'' significantly. However, the aminoacylation efficiency 
(Vmax/KJ of the double mutant U74U75 is reduced 180 fold compared to that of wild 
type tRNA^®" (Table 4), It appears that the cumulative effects of the double mutation on 
the aminoacylation activity of tRNA^"' is greater than a simple multiple of the relative 
efficiency (V^/KJ of each single mutation. 
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Function of 3' CvtMinRs nf tRNA^**!!! Polypeptide Synthesis 
Results showing that tRNA^** variants at position 74 and 75 can function in later 
steps of polypeptide synthesis were also obtained. All tRNA^®* mutants at position 74 are 
moderately active in poly(U,G)-directed (Val, Phe) copolypeptide synthesis, having 
polypeptide synthesis activities that are about 50% that of wild type tRNA"^®* (Figure 11). 
tRNA^®* variants, U75 and A75, are moderately active in polypeptide synthesis (Figure 
13). Evidently, cytidine residues at positions 74 and 75 of tRNA^'' are not absolute 
requu-ements for tRNA to function in polypeptide synthesis. The study by O'Connor et 
al. (45) showed that tRNA^*^ variants with substitutions at position 74 are active as valine 
donors in protein synthesis in vivo, which is consistent with our results from in vitro 
studies. O'Connor et al. also found that nucleotide substitutions at position 74 of 
tRNA^®' cause misreading at a stop codon 3' to the valine codon. This implies that 
disruption of the interaction between the 3' end of tRNA and the large ribosomal subunit 
affects the interaction of the next incoming tRNA wifli the 3' codon associated with the 
small subunit. The results also suggest that when a tRNA with a mutated 3' end is bound 
to its cognate codon in the ribosomal P site, the ability of die ribosomal A site to 
discriminate the binding of cognate and near-cognate tRNAs is reduced, and as a result, 
the fidelity of protein synthesis is affected. 
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Recognition of E. coli tRNA^"' by valyl-tRNA synthetase (VRS) 
In the course of studying the recognition of E. coli tRNA^"^ by its synthetase (VRS), 
transcripts of tRNA^*^ variants were prepared to investigate the identity elements of this 
tRNA. Steady-state kinetic studies of the aminoacylation of these tRNA variants were 
carried out to determine the effects of each mutation on the activity of tRNA^"^. E. coli 
tRNA^ and tRNA^' were used as models to further investigate the positive elements that 
are required to convert a noncognate tRNA to a valine acceptor, and to identify the 
negative determinants tiiat act to prevent proper recognition of the tRNAs by VRS. We 
also correlate structural information obtained by "F NMR studies of the tRNA^"^ variants 
with their aminoacylation activities to define the identity elements of tRNA^®*. 
Recognition of the Discriminator Base of tRNA^** bv VRS 
The discriminator base A73 is phylogenetically conserved in E. coli tRNA^"*, and 
was shown to be of some importance in recognition by VRS (124). Our study also 
indicates that the discriminator base A73 is involved in tRNA^'^ recognition by VRS. 
Substitution of A73 with C or U yields tRNA^®' mutants that retain 40-50% 
aminoacylation efficiency compared to wild type tRNA^®' (Table 9). 
Replacement of A73 by G73, however, yields a tRNA with a relative V^/K„ value that 
is 55 fold lower than that of wild type tRNA^*' (Table 5). These results suggest that 
although A73 is not essential for efficient charging of tRNA^®*, mutations introduced into 
this position do affect the activitj' of tRNA^"*. Based on the results obtained here, the 
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behavior of tRNA^*' variants at position 73 in aminoacylation may be explained by the 
following possibilities: 1) A73 is not specifically recognized by VRS, but G73 may act as 
a negative determinant to prevent proper recognition of tRNA^** by VRS; or 2) the 
discriminator base A73 of tRNA^®* interacts with VRS by hydrogen-bond formation, and 
C and U at this position can partially maintain this interaction with VRS. It is possible 
that C and U, but not G, introduced into position 73 of tRNA^"*, share some common 
functional groups or hydrogen bonding pattern with A, that permits the mutant tRNA to 
function in aminoacylation (Figure 20). Interestingly, the order of aminoacylation 
activity of tRNA^®' variants at position 73 and position 76 (the 3' terminus of tRNA) was 
found to be the same (Table 3 and 5). It is possible that the exocyclic amino group at 
position N6, and the ring N1 of the discriminator base adenosine may also be involved in 
hydrogen-bonding with amino acids at the active site of VRS, since a similar pattern of 
hydrogen bond donor (d) and acceptor (a) of A73 can also be found in C73 and U73, but 
not in G73 (Figure 20). These results suggest that VRS discriminates against noncognate 
tRNAs which contain G at the discriminator base position. 
It has been shown that the nature of the discriminator base influences the structure 
and stability of die acceptor stem end of tRNA"®', which is shown to be important for the 
recognition of the tRNA by Met-tRNA transformylase (148). It was also shown that the 
nature of die discriminator base influences the structure and stability of the acceptor stem 
of tRNA'^, which plays a significant role in tRNA^ recognition by alanyl-tRNA 
synthetase (149). "F NMR studies of 5-fluorouracil-substituted tRNA^'^ mutant G73 
showed that there is little difference between the ^®F NMR spectrum of the G73 mutant 
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and that of wild type (FUra)tRNA^*' (150), suggesting that the global conformation, 
including that of the acceptor stem, of the tRNA is not affected by the mutation. 
Tamura et al. also reported the role of position 73 as an identity site (124). They 
found, like we did, that the C73 mutant is most active among the variants at position 73 
of tRNA^*^. However, they also reported that changing A73 to U73 yields a tRNA 
mutant with very low aminoacylation activity (124). These results are quantitatively 
different from ours. The reason for the discrepancy is unclear. It was shown that plant 
Turnip Yellow Mosaic virus RNA can be efficiently recognized and aminoacylated by E. 
coli VRS (151, 152). Study of the recognition of the vurus RNA by wheat germ valyl-
tRNA synthetase (VRS) shows that the two nucleotides (A and C), located at position 
analogous to anticodon positions 35 and 36 of tRNA^®*, are very important for the 
recognition of the viral RNA by wheat germ VRS (153). In addition, the nucleotide 
located at a position analogous to the discriminator base A73 of tRNA^*", is also found to 
be a recognition site of this molecule. Changing A at this position to G in the RNA has a 
much greater negative effect on the relative efficiency (Vnu„/KJ of the RNA than 
changing the A to C. The discriminator base A73 is also a recognition site of some other 
tRNAs, including tRNA^, tRNA^", tRNA'^''^ tRNA^" and yeast tRNA""' (see 
Introduction). Among the cognate synthetases for these tRNAs, MetRS and LeuRS 
belong to the same subclass of class I synthetases as VRS (76). Mutations introduced 
into the discriminator base position of tRNA^" have slightly different effect from those 
introduced into the same position of E. coli tRNA^^ (89). Whereas in the case of 
tRNA^**, the order of activity of the discriminator base variants is C>U> > G, it was 
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found that the order of activity of the discriminator base mutants of tRNA®^" is U>G>C 
(89). It appears that recognition of the discriminator base A73 by different synthetases 
that belong to the same class, or even to the same subclass, differs. 
The involvement of the discriminator base in the recognition process is clearly seen 
in the case of E. coli glutaminyl tRNA complexed with glutaminyl-tRNA synthetase 
(GlnRS) (83). X-ray crystallographic studies of the E. coli tRNA®*"-GlnRS-ATP complex 
show several imusual structural changes at and near the 3' end of the tRNA. The final 
base pair of the acceptor stem (U1-A72) is disrupted and the 3'-acceptor end folds back 
toward the anticodon loop and stem, with A76, C75 and 073 stacked, while C74 is 
looped out. This unusual hairpin-like structure is stabilized by extensive interactions with 
GlnRS and by a sequence-specific RNA-RNA interaction between the 2-amino group of 
the discriminator base, G73, and a phosphate oxygen of A72. In the case of tRNA^*^, the 
discriminator base is adenosine, which does not contain the exocyclic 2-amino group, and 
the first base pair is G1-C72, rather than the A1-U72 found in tRNA®*". Our recent 
NMR studies suggest that the first base, G1-C72, of tRNA^*' is not disrupted in the 
complex of the tRNA and VRS (154). It is possible that the conformational changes at 
the 3' end of tRNA"^"* upon binding of VRS may not be the same as those found in the 
tRNA°'°-GlnRS recognition system. 
Recopnition of the Acceptor Stem of tRNA '^' bv VRS 
Many tRNAs contain recognition site(s) in their acceptor stems, especially in the 
upper region that is close to the 3' CCA end of the tRNA (89). Previous ''F NMR and 
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ribonuclease footprinting studies suggest that VRS makes contact with tRNA^*^ in the 
acceptor stem region, and the binding of VRS to tRNA^*' may induce conformational 
changes in the central and lower regions of the acceptor stem of the tRNA molecule (46, 
154). Therefore, the acceptor stem may contain specific site(s) for VRS recognition. 
The base pair U4-A69 was predicted to be an identity element of tRNA"^*^ by McClain et 
al., and is conserved in all the isoacceptors of E. coli and Salmonella tRNA^^. Tamura 
et al. (124) reported that changing the base pair U4-A69 to A4-U69 in tRNA^"^ decreases 
the aminoacylation activity of tRNA^** 9 fold and that replacement of the base pair G3-
C70 with C3-G70 in the acceptor stem reduces the activity of tRNA^"' 3 folds. They 
concluded that both U4-A69 and G3-C70 base pairs are identity elements of tRNA^'*. 
Our results, however, show that all of the mutants at positions 4-69 and 3-70, in the 
acceptor stem of tRNA^**, are quite active in aminoacylation, as long as Watson-Crick 
base pairs, rather than wobble base pairs, occur at these two positions (Table 6, 7). This 
suggests that the functional groups of the two base pairs, U4-A69 and G3-C70, are not 
directly recognized by VRS. This conclusion was supported first by NMR studies of 
FUra-substituted tRNA^** variants in the acceptor stem (Table 8) (Figure 13, 14), and was 
further supported by investigating the activity of E. coli tRNA^ and tRNA^® variants in 
aminoacylation with valine. 
In order to study the effect of acceptor stem mutations on the conformation of 
tRNA^*^, we have carried out "F NMR studies of several 5-fluorouracil-substituted 
tRNA^®" variants, including those containing a G-U wobble base pair at different positions 
in the acceptor stem. Our ^®F NMR studies show that many mutations introduced into the 
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base pair positions 1-72, 2-71 and 3-70 have no effect on the conformation of the 
acceptor stem and the global structure of tRNA^*^ (Figure 13, 14) (Table 8). Introducing 
a G-FU base pair into the base pair position 2-71, 3-70, and a FU-G base pair into the 
position 4-69, causes a gradual downfield shift of the resonance corresponding to FU4 
toward the central region of the "F spectrum where those resonances that correspond to 
FU residues in single-stranded regions of tRNA^*' are located. This suggests that the 4-
69 base pair may be at least partially opened or disrupted when a G-U base pair is 
located at 3-70. This notion is fiirther supported by studies showing that G-U wobble 
base pair may cause helix deformation in RNA double helices (119). Our study indicates 
that there is a strong correlation between the chemical shift of resonance FU4 in die ''F 
NMR spectrum of different tRNA mutants and their relative charging efficiency. The 
further downfield resonance FU4 shifts, the lower the aminoacylation activity the tRNA 
mutant (Table 8). Thus, our results show that maintaining a normal A-form RNA helix 
geometry around base pair U4-A69 is important for proper recognition of tRNA^'' by 
VRS. 
It is possible that introducing a G-U base pair into the 4-69 or 3-70 positions affects 
the conformation of the upper part of ±e acceptor stem, and consequently, the orientation 
of the 3'-end of tRNA^*^ relative to the active site of VRS, thus affecting the 
aminoacylation activity of tRNA"^"^. It is more likely that introducing a G-U base pair 
into the 3-70 or 4-69 position results primarily in a change in the local conformation of 
the acceptor stem aroimd position 4-69, that affects the recognition of the tRNA^®* 
variants by VRS. This idea is based on the facts that 1) only mutants containing G-U 
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base pairs at or close to position 4-69 of tRNA^"' retain low aminoacylation activity 
(Table 6). Other mutants containing a G-U wobble base pair at position 1-72 or 2-71 
retain significant aminoacylation activity, although these G-U wobble base pairs are 
closer to the 3' end of tRNA, and therefore, probably have more potential to alter the 
configuration or orientation of the 3' end of tRNA^®* than those located at position 3-70 
and 4-69; 2) introducing a G-U wobble base pair into position 6-67 or 7-66 in the 
acceptor stem may only appreciably affect the conformation around the base pair 
positions themselves, but not the conformation around 4-69 position, as suggested by the 
"F NMR studies of the tRNA mutants (Table 8) (Figure 13), yielding tRNA variants that 
still retain significant aminoacylation activity. Studies of crystal structures of A, B and Z 
form DNA octamers that contain G-T wobble base pairs showed that the G-T base pair 
affects only die local conformation around the mismatch, indicating that the G-T wobble 
base pair can be accommodated without appreciably affecting the global conformation of 
the DNA double helix (156). It is possible that VRS recognizes the conformation of the 
phosphate backbone and/or the sugar ring in a region that is at or close to 4-69 position 
of tRNA^"". Introducing a G-U base pair into the 3-70 or 4-69 position could affect this 
conformation. Studies by Musier-Forsyth and Schimmel show that alanyl-tRNA 
synthetase not only makes contact with the important G3-U70 base pair of tRNA'^, but it 
also interacts with the 2' -hydroxyl groups around the G3-U70 base pair of the tRNA, 
and these interactions play an important role in the tRNA-synthetase recognition (157). 
X-ray crystal structure studies of tRNA°'°-GlnRS (65) and tRNA^^-AspRS (68) 
complexes indicate that conformational changes of both tRNAs and synthetases occur 
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during the tRNA-synthetase recognition processes. Conformational changes in tRNA®*" 
occur m the anticodon, the acceptor stem, and the 3' end (158). In addition, interactions 
with the inside of the L-shaped tRNA have been shown by genetic studies to be important 
for transmitting accurate anticodon recognition signal to the active site of the synthetase 
(159). It is possible that a conformational change of the acceptor stem around position 
4-69 of tRNA^*' is involved in tRNA-VRS interaction. In this regard, a degree of helical 
flexibility (or rigidity) around the 4-69 position of the acceptor stem may be required for 
the proper conformational change during the tRNA-synthetase recognition process. 
Introducing a G-U wobble base pair into position 3-70 or 4-69 of tRNA^"* might cause 
deformation of the RNA helix around 4-69 position, which would affect the 
conformational change of the acceptor stem around this position. On the other hand, 
reinforcing the rigidity or the strength of the acceptor stem around the 4-69 position, by 
changing the base sequence, to generate a tRNA mutant with a acceptor stem more rigid 
than that of wild type tRNA^"', may also affect the conformational change, and as a 
result, the aminoacylation activity of the tRNA. 
Taken together, our results suggest that the functional groups on the U4-A69 base 
pair are probably not directly recognized by VRS. It is likely that the acceptor stem 
conformation around the 4-69 position is recognized by VRS, and possibly the proper 
conformational changes of the acceptor stem centering around the position 4-69 of 
tRNA^®" play a significant role in the recognition of this tRNA by VRS. 
Previous studies showed that the discriminator base and one or more of the first 4 
base pairs of the acceptor stem uniquely define 18 of the 20 ammo acid-specific E.coli 
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tRNAs and their isoacceptors (160). tRNA^*^ and tRNA^^" are not included in the 18 
tRNAs which contain defined base(s) or base pair(s) in the acceptor stem that are directly 
recognized by their cognate synthetases. In the case of tRNA^'', our studies suggest that 
VRS may make contact with the backbone of acceptor stem of the tRNA around the 4-69 
position, instead of with the base portion of the nucleotides at this position. This 
indicates that it is not the identity of the 4-69 base pair in the acceptor stem of tRNA^"^, 
but the conformation, and perhaps also the helical rigidity around this position, that is 
important for the recognition of tRNA^"^ by VRS. If this is true, then it is possible that 
different acceptor stem sequences around the 4-69 position of tRNA^"* may affect the 
conformation and/or the rigidity of the RNA double helix around position 4-69, and as a 
result, affect the activity of tRNAs. In other words, different acceptor stem 
conformations and/or rigidity around position 4-69 of noncognate tRNAs may act as 
negative determinants to prevent proper recognition by VRS. E. coli tRNA^ and 
tRNA^° contain a G-U wobble base pair at position 3-70 and 4-69 position respectively. 
The G3-U70 wobble base pair in tRNA^ clearly acts as a negative determinant to inhibit 
recognition of the tRNA by VRS (Table 15). It is also possible that the G4-U69 base 
pair in tRNA'^ prevents efficient interaction of this tRNA with VRS. In this respect, the 
discrimination of VRS against tRNA^®* variants containing a G-U base pair at position 3-
70 or 4-69 may have more general evolutionary significance. On the other hand, 
although E. coli tRNA"^, tRNA^, tRNA"", and tRNA"-^" contain U4-A69 base pairs in 
their acceptor stems, the distinctive sequence contexts around the 4-69 position in these 
tRNAs may affect the conformation and probably the helical rigidity around the 4-69 
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position and thus prevent proper recognition of these tRNAs by VRS. In contrast, 
although some tRNA^"* variants do not contain the U4-A69 base pair, they are still quite 
active in aminoacylation, probably because the acceptor stem conformation and/or the 
helix rigidity around 4-69 position of the mutants is not changed significantly. 
The significance of the conservation of U4-A69 base pair in tRNA^"^ isoacceptors 
requires further investigation. It is possible that it may act as a negative determinant to 
prevent recognition by noncognate synthetase, and thus prevent charging of tRNA'^®' by 
noncognate amino acids. 
Recognition bv VRS of Re^ons Other than the Anticodon Loop and Acceptor Stem 
oftRNA^" 
Besides the anticodon loop, the discriminator base position, and the acceptor stem of 
tRNA^®*, results obtained so far indicate that the variable pocket of tRNA^®* may contain 
VRS recognition sites. As mentioned above, the variable pocket is formed by the tertiary 
interaction between the D-loop and T-loop of the tRNA, and is the location of nucleotides 
16, 17, 20, 59 and 60. Mutations introduced into positions 17 and 59 do not affect the 
aminoacylation activity of tRNA^** variants significantly (Table 10). However, changing 
the base G20 in the variable pocket to any other nucleotide results in a 3-4 fold decrease 
in the aminoacylation activity (Vn^x/KJ of tRNA^"^. Three possibilities exist to explain 
these results: 1) G20 is directly recognized by VRS; 2) G20 not only makes contact with 
VRS, it also plays a role in helping maintain the tertiary structure of tRNA^"^; 3) G20 
only plays a role in maintaining the tertiary structure of tRNA^®*. 
138 
In order to understand the effect of the mutations at position 20 on the global 
structure of tRNA^"', a NMR study of (FUra)-substituted tRNA^"^ mutant C20 was 
carried out. The ''F NMR spectra of wild type and mutant C20 (FUra)tRNA^'' were 
recorded at 22°C (Figure 15) and 47°C (Figure 16). The spectrum of the C20 mutant, at 
22°C, is generally similar to that of wild type (FUra)tRNA^'', however, a few differences 
are observed (Figure 15). Resonance FU59 shifts upfield to a position between 5.2-5.4 
ppm, and the intensity of the peak decreases, due to peak broadening (Figure 15). In 
addition, resonance FU54 shifts approxunately 0.15 ppm upfield, and two peaks that 
correspond to resonances FU33/FU47 and resonance FU17 shift 0.1 ppm downfield 
(Figure 15). These results indicate that introducing C at position 20 changes the chemical 
environment around residue FU54, suggesting that the tertiary interaction involving FU54 
and FU58 is affected. Introducing C at position 20 probably also changes the chemical 
environment of FU59, since resonance FU59 shifts upfield in the "F spectrum of the 
mutant. The ^®F NMR spectrum of the mutant, recorded at 47°C, also clearly shows that 
resonance FU59 shifts 0.2 ppm upfield (Figure 16). Although the chemical shift position 
of resonance FU17 remains almost unchanged, its relative peak intensity, increases 
compared to the spectrum of the mutant recorded at 22°C. In addition, the resonance 
corresponding to FU47 appears to shift downfield to overlap with FU33, resulting in an 
increase in its peak intensity. It is difficult to determine whether resonance FU33 shifts 
under these condition. Taken together, our results show that replacing the wild type G 
with C at position 20 of tRNA^"* causes changes in the chemical shift positions or the 
peak intensity of at least three resonances that correspond to FU59, FU47, and FU54 
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(Figure 16, 17), suggesting that the tertiary structure as well as the variable pocket 
conformation of tRNA^"* is altered. 
As mentioned above, it was found that nucleotides 16, 17, 20, 59 and 60 are 
clustered together to form a variable pocket that arches out from the surface of yeast 
tRNA^' (119). tRNA^®* may also possess this kind of structure, since in general, all 
tRNA molecules adopt a similar L-shaped structure. It is possible that changing the 
nucleotide at position 20 could affect the chemical environment of the neighboring 
nucleotide FU59, directly or indirectly. In the crystal structure of yeast tRNA^*", G18 
and G19 in the D-loop, right next to G20, are involved in tertiary hydrogen bonding with 
U55 and C56 in the T-loop. Base U54, right next to U55, in the T-loop also interacts 
with A58 through tertiary hydrogen bonding. It is therefore possible that changing G20 
to C20 in tRNA^*^ somehow affects these tertiary interactions, resulting in a tRNA 
molecule with an altered three dimensional structure. 
Base substitutions at position 20 were shown to affect the three dimensional 
structure of E. coli tRNA"". Wild type E. coli tRNA"'® contains U at position 20. 
Uhlenbeck and co-workers showed that changing U20 to any other nucleotide alters the 
lead cleavage pattern of the tRNA variants, suggesting that the structure of tRNA'"'® in the 
region where the T-loop/D-loop interactions occur is affected as a result of the mutations 
(161). They ascribed the effects of one of the mutations (G20) on tRNA structure to the 
generation of three consecutive G's in the D-loop of the tRNA and proposed that an 
alternate conformation of the tRNA"*' mutant G20 may exist. However, the effects of 
other two mutants, A20 and C20, on the conformation of E. coli tRNA"*' were never 
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explained. Effects of D-loop sequence on the conformation of E. coli tRNA"*' were also 
found by McClain et al. (162) who showed that the addition of a nucleotide in the iS 
region of the D-loop prevents tRNA"*® from being normally processed. This implies that 
a structural defect may occur in the precursor tRNA that makes it unsuitable as a 
substrate for RNase P. This effect, however, is compensated for by the coincident 
substitution of U59 by A59, suggesting that sequences in the T-loop that are spatially 
close to nucleotides in the D-loop, influence the structure of E. coU tRNA^'. Our "F 
NMR results are similar to the findings with E. coli tRNA^® by McClain et al., and show 
that introducing a C into position 20 of tRNA^*^ changes the chemical shift position of 
resonances FU59 and FU54, indicating that the three dimensional structure involving the 
D-loop and T~loop of tRNA^** is altered. 
Our aminoacylation kinetic studies showed that changing G20 to any other 
nucleotide results in a 3-4 fold decrease m aminoacylation activity of tRNA^**. The effect 
of the other two mutants, A20 and U20, on the structure of the tRNA may be similar to 
that of the mutant C20, since the kinetic parameters ( Km and of these three mutants 
are very similar (Table 10). It is unclear at this point whether the low aminoacylation 
activity of tRNA^*" variants at position 20 is due solely to the structural perturbations of 
the tRNAs, or whether the low activities of the mutants are also due partially to a loss of 
contact between VRS and some functional groups on the G at position 20 of wild type 
tRNA^®*, which may play a role in the recognition of tRNA^"' by VRS. Studies show that 
conformational changes affect the aminoacylation activity of different tRNAs differently 
(163). It was found that AlaRS and VRS are two synthetases that are insensitive to the 
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overall conformation of their cognate tRNAs (164, 165). 
In many tRNAs, U8 forms tertiary hydrogen bonds with A14 and plays an 
important role in stabilizing the three dimensional structure of the molecules. NMR 
studies of tRNA^®^ show that introducing mutations (A, C or G) into position 8 of this 
tRNA causes dramatic changes m the whole "F NMR spectrum of (Fura)tRNA^'^, 
suggesting that the three dunensional structure, including the anticodon loop structure, of 
tRNA^** is greatly disrupted as a result of the mutations (166). The tRNA^®* variants, AS 
and C8, however, retain significant aminoacylation activities. These results support the 
notion that VRS is quite insensitive to the conformational change of tRNA^"^. In this 
respect, a tRNA mutant with much less perturbation in its three dimensional structure, 
compared to the structural changes of tRNA^** mutants at position 8, would retain much 
higher aminoacylation activity than mutants A8 and C8. However, this kind of situation 
does not happen to the tRNA^"* mutants at position 20. The mutants at position 20 retain 
low aminoacylation activity (Table 10), even though their three dimensional structures are 
much more intact than those of tRNA^*^ mutants at position 8. In other words, the 
possible cause of the low aminoacylation activities of tRNA^** mutants at position 20 may 
be due to not only the changes in their variable pocket and three dimensional structures, 
but also due to the loss of proper contact between VRS and the functional groups of the 
G at position 20. Therefore, it is possible that the G at position 20 may be a recognition 
site of tRNA^**. Changing the G to any other nucleotide will disrupt proper interaction of 
tRNA^^with VRS. This idea is further supported by the study of ammoacylation of E. 
coli tRNA"'' variants with valine (Table 12). 
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Previous studies showed that changing die base pair U29-A41 to C29-G41 in the 
anticodon stem of tRNA^"' decreases the aminoacylation activity of the tRNA significantly 
(138). Kinetic study of the mutant in which C29-G41 replaced U29-A41, showed that the 
relative specificity constant of this mutant was reduced to only 0.026. Changing base 
pair U29-A41 to U29-G41 generates a tRNA mutant with a relative V^/Kn, value of 
0.22. In contrast, mutant tRNAVal containing A29-U41 in place of U29-A41 is active in 
aminoacylation. Mutant 29C-41G has five C-G base pairs in the anticodon stem, and in 
this respect, bears a structural resemblance to initiator methionine tRNAs. Both 
prokaryotic and eukaryotic initiator tRNAs contain a sequence of three consecutive G-C 
base pairs in the anticodon stem. A study by Wrede et al. (167) showed that the 
conformation of the anticodon loop of initiator tRNAs differs from that of elongator 
tRNAs and the structure differences are due to the three consecutive G-C base pairs in 
the anticodon stem. It's not yet clear whether the poor binding of mutant C29-G41 to 
VRS is due to conformational change in the anticodon loop structure, or whether the 
U29-A41 base pair interacts direcdy with VRS. It is also possible that replacement of 
U29-A41 with C29-G41 may create a negative element which prevent the molecule from 
being recognized by VRS. "F NMR spectrum of the C29-G41 mutant, recorded at room 
temperature, shows changes in the chemical shifts of resonances of signals 
corresponding to FU residues in the anticodon loop. This indicates that changing the U-
A base pair to C-G at position 29-41 affects the conformation of the anticodon loop. 
However, the ''F NMR spectrum of the C29-G41 mutant, recorded at 47°C, does not 
show these spectral differences. Kinetic study of this mutant at 47°C shows that the 
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specificity constant remains almost unchanged compared to that obtained at 37°C. Mutant 
tRNA^"* having A29-U41 base pair is active in aminoacylation (Table 9), probably 
because of the similar patterns of the hydrogen bond donor and acceptor groups in the 
minor groove side of either base pair U29-A41 or A29-U41 that provide common 
structural features for VRS to recognize. It is, therefore, possible that this base pair is a 
recognition site of tRNA^"^. Kinetic study shows that changing the wild type C30-G40 to 
U30-A40 does not reduce the aminoacylation activity of the tRNA significantly, 
suggesting that this position is probably not recognized by VRS. This conclusion was 
supported further by the study of aminoacylation of tRNA^ with valine (Table 11) 
Positive and Negative Recognition Elements of tRNA^** bv VRS: Mentitv Switch 
Experiments with E. coli tRNA  ^and tRNA^*" 
tRNA^ Variants 
The G3-U70 wobble base pair is a very important recognition site of E. coli 
tRNA^ (see Introduction). The tRNA^ isoacceptor having the anticodon UGC is a very 
poor substrate for VRS (Table 11). Changing 035 to A35 yields a tRNA'^ variant with 
the valine anticodon UAC, and this tRNA has a relative value for aminoacylation 
with valine of 0,16 compared to that of wild type tRNA^*^ (Table 11) (Figure 17). An 
additional change of U70 to C70 in tRNA^ , which removes the G-U wobble base pair 
at position 3-70 in the acceptor stem, converts it to a very good substrate for VRS, with a 
relative value of 0.94. These results suggest that either the G3-C70 base pair is 
a recognition site of tRNA^'', or replacing the G3-U70 wobble base pair with G3-C70 
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base pair removes a negative determinant, yielding a tRNA^ variant active in valylation 
(Table 11) (Figure 17). To find out whether the G3-C70 is a identity site of tRNA^®*, a 
tRNA'^ variant containing the valine anticodon (UAC) and an A3-U70 base pair was 
made and found to be quite active in valylation (Table 11) (Figure 17). The above two 
tRNA"^ variants are quite active in valine-charging despite the absence of a A4-U69 base 
pair which was predicted to be an identity element of tRNA^*^. Taken together, 
aminoacylation studies of tRNA^ variants with valine support the conclusions from 
studies with tRNA^"* variants, that the anticodon base A35 is very important for the 
aminoacylation activity of tRNA^"*. The results also show that the U4-A69 base pair 
does not contain functional groups that are directly recognized by VRS, and suggest that 
a G-U base pair in the acceptor stem of tRNA^' acts as a negative determinant to prevent 
proper recognition of tRNA'^ by VRS. The low aminoacylation activity of the mutant 
tRNA'^(UAC) containing a G-U base pair at position 3-70 is probably due to the 
presence of the unique wobble base pair geometry, since all the other tRNA^"' and 
tRNA'^ variants (UAC anticodon) at the same base pair position retain high 
aminoacylation activity. 
The C30-G40 base pair in the anticodon stem of tRNA^®' was predicted by McClain 
et al. to be a recognition site of the tRNA (see Introduction). Study of the recognition of 
tRNA'^ variants by VRS shows that the tRNA'^ mutant (UAC), containing a G-C base 
pair at position 30-40, in the anticodon stem, is actively aminoacylated with valine (Table 
15). This suggests that this base pair is not important for the activity of tRNA^"*. 
These studies support the conclusion that: 1) the U4-A69 and G3-C70 base pairs of 
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tRNA^"* are not directly recognized by VRS; 2) introducing Watson-Crick base pairs in 
the 3-70 base pair position of the acceptor stem of tRNA^"^ and tRNA'^ has little effect 
on the activity of the tRNA mutants. However, introducing G-U wobble base pair into 
the 3-70 of bodi tRNA^"* and tRNA'^, and particularly into the 4-69 position of tRNA^"^ 
reduces the aminoacylation activity of tRNA^*^ significantly (Table 6, 11). 
tRNA"" Variants 
Our results show that the anticodon bases A35, C36, and the discriminator base A73 
are identity elements of tRNA^"*. In addition, G20 in the variable pocket is also a 
possible recognition site of this tRNA. It is unclear whether inserting these recognition 
sites into noncognate tRNAs is capable of changing the identity of the tRNAs into a 
valine-accepting species. It is possible that different noncognate tRNAs contain different 
negative determinants that prevent the proper recognition of these tRNAs by VRS. For 
these reasons, it is not sufficient to study the recognition of only one noncognate tRNA, 
tRNA^, by VRS. In order to further investigate the recognition of tRNA^"^ by VRS, and 
determine the negative elements in other tRNA species that prevent proper recognition of 
the noncognate tRNAs by VRS, E. coli tRNA"" (anticodon GAA) was chosen for study. 
Figure 18 shows a sequence comparison between tRNA^"' and tRNA"". There are 
32 nucleotides that differ between the two tRNAs. Wild type tRNA^'" is a very poor 
substrate for VRS (Table 12). Figure 19 shows the mutations introduced into tRNA""® to 
convert the tRNA into an active valine-chargmg tRNA. Replacement of A by C at 
position 36 increases the activity of tRNA""® significantly. However, this tRNA is still a 
poor substrate for VRS, having only 1% the activity of wild type tRNA^®' even though 
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this tRNA contains the anticodon bases A35, C36, and the discriminator base A73 that 
are the major tRNA^"* recognition elements. An additional change of U20 to G20, in the 
variable pocket of the tRNA, increases the aminoacylation activity 3.7 fold (Figure 19). 
However, the relative activity (Vn„x/KJ of this tRNA is still only 3.7% that of wild type 
tRNA^®^ (Table 12). Additional mutations were simultaneously introduced into die upper 
three base pair positions (27-43 to 29-41) of the anticodon stem of the tRNA"*® variant 
that contains A35 and G20, resulting in a tRNA molecule that contains exactly the same 
three base pair sequence as tRNA^** in this region of the molecule (Figure 19). This 
mutant tRNA^® has a relative aminoacylation efficiency (V^/K^ 40% that of wild type 
tRNA^®". These results suggest three possibilities: 1) the upper part of the anticodon stem 
of tRNA^®* contains identity elements that are missing in tRNA"*®; 2) the anticodon stem 
of tRNA^® does not contain positive recognition elements, but contains some negative 
determinants which prevent proper recognition of the tRNA by VRS, presumably by 
blocking local interaction between the anticodon stem and VRS; or 3) the upper part of 
the anticodon stem of tRNA'"'"® is not directly against recognition by VRS, but it 
contributes to the specific conformation of the anticodon loop of this tRNA which inhibits 
proper recognition by VRS. Changing the anticodon stem sequence might cause long-
range conformational changes in the anticodon loop of tRNA^', creating a tRNA^**' 
variant that can be recognized by VRS and is active in aminoacylation with valine. 
Previous ^®F NMR studies suggest that mutations introduced into the anticodon stem of 
tRNA^'^can cause conformational changes in the anticodon loop of this molecule (139). 
Changing base pair U29-A41 to C29-G41 in the anticodon stem of tRNA'^*' causes 
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changes in the chemical shift position of resonance FU33 and FU34 in the NMR 
spectrum of (FUra)tRNA^"', suggesting a conformational change in the anticodon loop, 
which may be partially responsible for the dramatic decrease in the aminoacylation 
activity of this tRNA (Table 9). On the other hand, tRNA footprinting experhnents show 
that VRS protects position 43 against digestion of tRNA^*^ by ribonuclease, suggesting 
that VRS may make contact with the base pair C27-G43, in the upper part of the 
anticodon stem of tRNA^"^. It is possible that the increased valylation activity of the 
tRNA"" variant, as a result of the mutations from position 27-43 to 29-41 in this tRNA 
(Table 12), is due to the combination of the loss of negative determinant(s) and the 
obtaining of positive recognition elements in the anticodon stem of tRNA"*®. Further 
studies need to be carried out to define the exact effect of each base pair, in the upper 
part of the anticodon stem, on the structure and activity of tRNA^' in aminoacylation 
with valine. 
Our study shows that changing nucleotide U20 to G20 increases the aminoacylation 
activity of E. coli tRNA^® 3.7 fold. As mentioned above, changing nucleotide U20 to 
G20 in E. coli tRNA""" affects the variable pocket conformation and the three dimensional 
structure of this tRNA (161). Introducing G at position 20 may then change the structure 
of this tRNA to one that is favored by VRS recognition, resulting in increased 
aminoacylation activity. It is certain that U at position 20 of E. coli tRNA^' acts as a 
negative determinant to prevent proper recognition of this tRNA by VRS. Further 
investigations are required to determine whether the G at position 20 of tRNA^®' is really 
a true recognition site of this tRNA. Yeast tRNA''*'® would be a perfect model in that it 
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has a unique variable pocket whose three dimensional structure is found to be insensitive 
to mutations at position 20 (168). 
Taken together, our study demonstrates that in addition to the anticodon bases A35 
and C36 diat are very important for the activity of tRNA^*", the discrimmator base A73 is 
also recognized by VRS, in a specific manner. Furthermore, the base G at position 20 of 
tRNA^®* may also be a recognition site of this tRNA. Our study suggests that it is the 
specific conformation of the acceptor stem around the 4-69 position of tRNA^°', but not 
the U4-A69 base pair itself, that is recognized by VRS and plays a role in tRNA-VRS 
recognition. 
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